Processing 00000000.tx.1: Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* Kazuhiro Honda, Mark A. 

Phrase: "Ribosomal RNA in Alzheimer Disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1622954:ribosomal RNA [Cell Component]
   760   C0035553:Ribosomal [Cell Component]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Is"

Phrase: "Oxidized by Bound Redox-active Iron"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0030012:Redox [Molecular Function]
   753   C0205177:Active [Functional Concept]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0332297:bound [Spatial Concept]
           Bounded by
   753   C0376520:Iron [Inorganic Chemical]
   753   C1145667:Bound [Activity]
   753   C1166521:iron [Pharmacologic Substance]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   719   C0030011:oxidize [Molecular Function]

Phrase: "* Kazuhiro Honda,"

Phrase: "Mark A."
Processing 00000000.tx.2: Smith, Xiongwei Zhu, Diane Baus, William C. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "Xiongwei Zhu,"

Phrase: "Diane Baus,"

Phrase: "William C."
Processing 00000000.tx.3: Merrick, Alan M. 

Phrase: "Merrick,"

Phrase: "Alan M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Tartakoff, Thomas Hattier, Peggy L. 

Phrase: "Tartakoff,"

Phrase: "Thomas Hattier,"

Phrase: "Peggy L."
Processing 00000000.tx.5: Harris, Sandra L. 

Phrase: "Harris,"

Phrase: "Sandra L."
Processing 00000000.tx.6: Siedlak, Hisashi Fujioka, Quan Liu, Paula I. 

Phrase: "Siedlak,"

Phrase: "Hisashi Fujioka,"

Phrase: "Quan Liu,"

Phrase: "Paula I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.7: Moreira, Frank P. 

Phrase: "Moreira,"

Phrase: "Frank P."
Processing 00000000.tx.8: Miller, Akihiko Nunomura||, Shun Shimohama**, and George Perry From the Institute of Pathology, Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, the Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-517 Coimbra, Portugal, the ||Department of Psychiatry and Neurology, Asahikawa Medical College, Asahikawa, 078-8510 Japan, and the **Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan Received for publication, January 14, 2005 , and in revised form, March 4, 2005.  

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "Akihiko Nunomura||,"

Phrase: "Shun"

Phrase: "Shimohama"

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "George Perry From the Institute of Pathology,"

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028905:Ohio [Geographic Area]

Phrase: "the Center for Neuroscience"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Cell Biology of Coimbra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   770   C0005532:Biology [Biomedical Occupation or Discipline]

Phrase: "University of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "3004-517 Coimbra,"

Phrase: "Portugal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]

Phrase: "the ||Department of Psychiatry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587494:Psychiatry department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "Asahikawa Medical College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0557806:College [Manufactured Object]

Phrase: "Asahikawa,"

Phrase: "078-8510 Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "the **Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587475:Neurology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Kyoto University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyoto 606-8507,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 14,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 4,"

Phrase: "2005."
Processing 00000000.tx.9: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Oxidative modification of cytoplasmic RNA in vulnerable neurons is an important, well documented feature of the pathophysiology of Alzheimer disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oxidative modification of cytoplasmic RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158744:RNA modification [Genetic Function]
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "in vulnerable neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "an important, well documented feature of the pathophysiology of Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C1521970:Feature [Qualitative Concept]
   738   C1706388:Feature [Conceptual Entity]
   738   C2346469:Feature [Qualitative Concept]
   738   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.10: Here we report that RNA-bound iron plays a pivotal role for RNA oxidation in vulnerable neurons in Alzheimer disease brain. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that RNA-bound iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role for RNA oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in vulnerable neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in Alzheimer disease brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.11: The cytoplasm of hippocampal neurons showed significantly higher redox activity and iron(II) staining than age-matched controls. 

Phrase: "The cytoplasm of hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   760   C0010834:Cytoplasm [Cell Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significantly higher redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1151028:redox activity [Molecular Function]
   861   C2266998:Redox Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining than age-matched controls."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.12: Notably, both were susceptible to RNase, suggesting a physical association of iron(II) with RNA. 

Phrase: "Notably,"

Phrase: "both"

Phrase: "were"

Phrase: "susceptible to RNase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231204:Susceptible [Functional Concept]
   790   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a physical association of iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(II"

Phrase: ")"

Phrase: "with RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.13: Ultrastructural analysis further suggested an endoplasmic reticulum association. 

Phrase: "Ultrastructural analysis further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an endoplasmic reticulum association."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.14: Both rRNA and mRNA showed twice the iron binding as tRNA. 

Phrase: "Both rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "the iron binding as tRNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1148613:iron binding [Molecular Function]
   797   C1148901:tRNA binding [Genetic Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.15: rRNA, extremely abundant in neurons, was considered to provide the greatest number of iron binding sites among cytoplasmic RNA species. 

Phrase: "rRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extremely abundant in neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the greatest number of iron binding sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0445108:Number of sites [Quantitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "among cytoplasmic RNA species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705920:Species [Conceptual Entity]
   734   C2827481:Cytoplasmic RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.16: Interestingly, the difference of iron binding capacity disappeared after denaturation of RNA, suggesting that the higher order structure may contribute to the greater iron binding of rRNA. 

Phrase: "Interestingly,"

Phrase: "the difference of iron binding capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "disappeared after denaturation of RNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1720790:RNA Denaturation [Natural Phenomenon or Process]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0301642:Denaturation [Molecular Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the higher order structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512460:Higher Order Structure [Cell Component]
   827   C0678594:Structure [Spatial Concept]

Phrase: "may"

Phrase: "contribute to the greater iron binding of rRNA."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C1148613:iron binding [Molecular Function]
   767   C1148884:rRNA binding [Genetic Function]
   744   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0443228:greater [Quantitative Concept]
   744   C1145667:Binding [Activity]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1167622:Binding [Molecular Function]
   744   C1704243:Greater [Quantitative Concept]
   744   C1880177:Contribute [Activity]
   711 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.17: Reflecting the difference of iron binding capacity, oxidation of rRNA by the Fenton reaction formed 13 times more 8-hydroxyguanosine than tRNA. 

Phrase: "Reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the difference of iron binding capacity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "oxidation of rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "by the Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "13 times more 8-hydroxyguanosine than tRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0050092:8-hydroxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.18: Consistent with in situ findings, ribosomes purified from Alzheimer hippocampus contained significantly higher levels of RNase-sensitive iron(II) and redox activity than control. 

Phrase: "Consistent with in situ findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]

Phrase: "ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "purified from Alzheimer hippocampus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "significantly higher levels of RNase-sensitive iron"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   774   C0337439:iron levels [Laboratory Procedure]
   774   C0428578:iron levels [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "redox activity than control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1151028:redox activity [Molecular Function]
   833   C2266998:Redox Activity [Molecular Function]
   783   C1706449:Active Control [Research Activity]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.19: Furthermore, only Alzheimer rRNA contains 8-hydroxyguanosine in reverse transcriptase-PCR. 

Phrase: "Furthermore,"

Phrase: "only Alzheimer rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "8-hydroxyguanosine in reverse transcriptase-PCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050092:8-hydroxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.20: Addressing the biological significance of ribosome oxidation by redox-active iron, in vitro translation with oxidized ribosomes from rabbit reticulocyte showed a significant reduction of protein synthesis. 

Phrase: "Addressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the biological significance of ribosome oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "by redox-active iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "in vitro translation with oxidized ribosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040712:Translation [Intellectual Product]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]

Phrase: "from rabbit reticulocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035286:Reticulocyte [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant reduction of protein synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.21: In conclusion these results suggest that rRNA provides a binding site for redox-active iron and serves as a redox center within the cytoplasm of vulnerable neurons in Alzheimer disease in advance of the appearance of morphological change indicating neurodegeneration.  

Phrase: "In conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a binding site for redox-active iron"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C0205681:Active Site [Functional Concept]
   774   C1148613:binding iron [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "serves as a redox center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030012:Redox [Molecular Function]
   760   C0205099:Center [Spatial Concept]

Phrase: "within the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of vulnerable neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in advance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725066:Advance [Medical Device]

Phrase: "of the appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "of morphological change"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   950   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   861   C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "indicating"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.22: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Free radical damage and oxidative stress play a pivotal role in the pathogenesis of Alzheimer disease (AD)1 (13). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Free radical damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in the pathogenesis of Alzheimer disease (AD)1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: Although oxidative damage is well documented in AD (49), the sources of reactive oxygen species triggering such damage to various macromolecules is yet to be identified. 

Phrase: "Although"

Phrase: "oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "well documented in AD"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205170:Well [Qualitative Concept]
   760   C1301725:Documented [Health Care Activity]
   760   C1609436:documented [Idea or Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C1301746:document [Intellectual Product]
   726 E C1547673:Document [Intellectual Product]

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "the sources of reactive oxygen species"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449416:sources [Finding]
   719 E C1705919:Source [Idea or Concept]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "such damage to various macromolecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "yet to"

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.24: Altered iron homeostasis is also reported in AD, including alteration in iron, ferritin, and transferrin (1015). 

Phrase: "Altered iron homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1156273:iron homeostasis [Cell Function]
   827   C0019868:Homeostasis [Biologic Function]

Phrase: "is"

Phrase: "also"

Phrase: "reported in AD,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "alteration in iron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515926:Alteration [Idea or Concept]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "transferrin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442762:TRANSFERRIN [Gene or Genome]
   916 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1015"

Phrase: ")."
Processing 00000000.tx.25: Interestingly, a recent study characterizes an iron-responsive element in the 5'-untranslated region of the Alzheimers APP transcript, indicating the post-transcriptional regulation of APP synthesis by iron (16). 

Phrase: "Interestingly,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "characterizes"

Phrase: "an iron-responsive element in the 5'-untranslated region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0205342:Responsive [Functional Concept]
   742   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0376520:Iron [Inorganic Chemical]
   742   C1166521:iron [Pharmacologic Substance]
   742   C1705248:Element [Conceptual Entity]
   726   C0876023:elemental iron [Inorganic Chemical,Pharmacologic Substance]

Phrase: "of the Alzheimers APP transcript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "indicating"

Phrase: "the post-transcriptional regulation of APP synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1514248:Post-Transcriptional Regulation [Genetic Function]
   804   C1157723:regulation of synthesis [Molecular Function]
   778   C1158770:Transcriptional Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.26: Because redox-active iron (Fe2+, iron(II)) has a potential to produce a highly reactive OH when it meets hydrogen peroxide (Fenton reaction; Fe2+ + H2O2 Fe3+ + OH + OH), iron is considered as the likely candidate to mediate oxidative stress in AD. 

Phrase: "Because"

Phrase: "redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "(Fe2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346592:Fe2+ [Element, Ion, or Isotope]

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: ")"

Phrase: "has"

Phrase: "a potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "produce"

Phrase: "a highly reactive OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "when"

Phrase: "it"

Phrase: "meets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "; Fe2+ + H2O2 Fe3+ + OH + OH"

Phrase: ")"

Phrase: ","

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "is"

Phrase: "considered as the likely candidate to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C0750591:considered [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "oxidative stress in AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.27: Redox-active iron-mediated oxidative damage to nucleic acids has been extensively studied in DNA (1719). 

Phrase: "Redox-active iron-mediated oxidative damage to nucleic acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0010957:Damage [Injury or Poisoning]
   742   C1883709:Damage [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "studied in DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "(1719"

Phrase: ")."
Processing 00000000.tx.28: Although the radical species produced by the Fenton reaction in DNA oxidization is still controversial (20), the location of oxidative damage is suggested as site-directed (21). 

Phrase: "Although"

Phrase: "the radical species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "produced by the Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "in DNA oxidization"

Phrase: "is"

Phrase: "still controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "the location of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "is"

Phrase: "suggested as site-directed"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]
   737   C0439851:Direct [Qualitative Concept]
   737   C1705535:Suggest [Idea or Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.29: As for RNA oxidization, recent studies have shown that the Fenton reaction oxidized and cleaved rRNA in cultured primary neurons (22). 

Phrase: "As for RNA oxidization,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "cleaved rRNA in cultured primary neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.30: RNAs are known to require divalent metals for functionality and proper folding. 

Phrase: "RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "divalent metals for functionality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0596455:divalent metal [Element, Ion, or Isotope]
   770   C0025552:Metals [Inorganic Chemical]

Phrase: "and"

Phrase: "proper folding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: It is known that physiologically Mg2+ is used for proper folding of RNAs (23) and redox-active iron has been shown to also bind with RNA at the metal binding site (24). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that physiologically Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417500:MG2 [Gene or Genome]
   861   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "used for proper folding of RNAs"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1514664:RNA Folding [Genetic Function]
   767   C1524063:Use of [Functional Concept]
   753   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185026:Folding [Therapeutic or Preventive Procedure]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "bind with RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "at the metal binding site"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1513163:Metal Binding Site [Amino Acid Sequence]
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   901   C1323274:metal binding [Molecular Function]
   827   C0025552:Metal [Inorganic Chemical]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   755 E C2986473:Metallic [Qualitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.32: Neurons are continuously exposed to reactive oxygen species, which are produced from the mitochondrial electron transport chain because of the high demand for molecular oxygen to maintain their function and metabolism (25% of total body oxidative metabolism is within the brain). 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "continuously"

Phrase: "exposed to reactive oxygen species,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "which"

Phrase: "are"

Phrase: "produced from the mitochondrial electron transport chain"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C1325653:Mitochondrial electron transport chain [Cell Component]
   814   C1752477:mitochondrial electron transport [Molecular Function]
   814   C2244392:electron transport chain [Molecular Function]
   778   C0013846:Electron Transport [Molecular Function]
   774   C0678851:mitochondrial transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0013852:Electron [Quantitative Concept]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0337112:Chain [Manufactured Object]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]
   748   C3463986:Electron [Bird]
   748   C3495449:transport [Medical Device]

Phrase: "because of the high demand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]

Phrase: "for molecular oxygen to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0302920:Molecular oxygen [Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "their function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "(25% of total body oxidative metabolism"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0229960:Total body [Fully Formed Anatomical Structure]
   790   C0282636:oxidative metabolism [Cell Function]
   783   C1636179:Total metabolism [Laboratory or Test Result]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0242821:body [Human]
   753   C0311404:Oxidative [Functional Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]

Phrase: "is within the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.33: To cope with this continuous reactive oxygen species production, neurons possess anti-oxidant machinery. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cope with this continuous reactive oxygen species production,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0009967:cope [Individual Behavior]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0033268:production [Occupational Activity]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0549178:Continuous [Idea or Concept]
   744   C1705920:Species [Conceptual Entity]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "anti-oxidant machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.34: Mitochondrial superoxide dismutase catalyzes the dismutation of superoxide to hydrogen peroxide, the latter being a membrane oxidant capable of reaching throughout the neuronal cytoplasm. 

Phrase: "Mitochondrial superoxide dismutase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0968147:Mitochondrial Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420307:SUPEROXIDE DISMUTASE, MITOCHONDRIAL [Gene or Genome]
   901   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "catalyzes"

Phrase: "the dismutation of superoxide"

Phrase: "to hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "the latter"

Phrase: "being"

Phrase: "a membrane oxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085403:oxidant [Chemical Viewed Functionally]

Phrase: "capable of reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "throughout the neuronal cytoplasm."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.35: Amyloid of senile plaques and other locations could also be a source of hydrogen peroxide, because it can catalyze superoxide dismutase-like reactions (25, 26). 

Phrase: "Amyloid of senile plaques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0333463:amyloid plaques [Acquired Abnormality]
   819   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other locations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0450429:locations [Spatial Concept]
   966 E C1515974:Location [Body Location or Region]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "a source of hydrogen peroxide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "because"

Phrase: "it"

Phrase: "can"

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "superoxide dismutase-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "like reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.36: To extinguish hydrogen peroxide, neurons have antioxidant machinery such as glutathione peroxidase and catalase. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extinguish"

Phrase: "hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "have"

Phrase: "antioxidant machinery such as glutathione peroxidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0337076:machinery [Manufactured Object]

Phrase: "and"

Phrase: "catalase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]
Processing 00000000.tx.37: However, it is likely the mitochondrial abnormalities in AD (27) increase production of reactive oxygen species making more hydrogen peroxide available to catalyze the Fenton reaction (28). 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "the mitochondrial abnormalities in AD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "(27"

Phrase: ")"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "production of reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "more hydrogen peroxide available to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0020275:Hydrogen [Element, Ion, or Isotope]
   804   C0031180:Peroxide [Inorganic Chemical]
   804   C0523702:HYDROGEN [Laboratory Procedure]
   804   C0885426:hydrogen [Inorganic Chemical]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.38: Fenton chemistry may be the mechanism for the extensive damage to all categories of macromolecules characterizing AD. 

Phrase: "Fenton chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007996:Chemistry [Occupation or Discipline]
   861   C0079107:chemistry [Classification]
   861   C0201682:Chemistry [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "the mechanism for the extensive damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "to all categories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0683312:Categories [Intellectual Product]
   966 E C1555713:category [Idea or Concept]

Phrase: "of macromolecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "characterizing"

Phrase: "AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.39: Previously we demonstrated that cytoplasmic RNA of vulnerable neurons is consistently oxidized in AD-vulnerable neurons (5). 

Phrase: "Previously"

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that cytoplasmic RNA of vulnerable neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2827481:Cytoplasmic RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "consistently"

Phrase: "oxidized in AD-vulnerable neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0012655:disease vulnerability [Clinical Attribute]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0027882:Neurons [Cell]
   719   C0030011:oxidize [Molecular Function]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.40: Because hydroxyl radical mediates oxidative modification of nucleic acids, in the present study we addressed whether redox-active iron is involved in the oxidation of cytoplasmic RNA in vulnerable neurons of AD, especially focusing on ribosomal RNA.  

Phrase: "Because"

Phrase: "hydroxyl radical"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0439807:Radical [Qualitative Concept]
   861   C0700307:Hydroxyl [Inorganic Chemical]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "oxidative modification of nucleic acids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "in the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "is"

Phrase: "involved in the oxidation of cytoplasmic RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C2827481:Cytoplasmic RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0030011:Oxidation [Molecular Function]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C1314939:Involved [Functional Concept]

Phrase: "in vulnerable neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "especially"

Phrase: "focusing on ribosomal RNA."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1622954:ribosomal RNA [Cell Component]
   770   C0000936:focusing [Clinical Attribute]
   770   C0035553:Ribosomal [Cell Component]
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C2981153:Focusing [Finding]
   737 E C0205234:Focus [Spatial Concept]
   737 E C1285542:focus [Functional Concept]
Processing 00000000.tx.41: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Nucleic AcidsBovine rRNA and tRNA were obtained from Sigma. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nucleic AcidsBovine rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "tRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "were"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.42: For the preparation of mRNA, total RNA was extracted from M-17 neuroblastoma cells by using TRIzol LS reagent (Invitrogen, Carlsbad, CA) and then mRNA was purified with Oligotex mRNA Mini kit (Qiagen, Valencia, CA). 

Phrase: "For the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0185115:Extracted [Therapeutic or Preventive Procedure]
   833   C3541890:EXTRACTED [Finding]
   799 E C2828366:Extract [Substance]

Phrase: "M-"

Phrase: "17 neuroblastoma cells by"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol LS reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "and"

Phrase: "then mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified with Oligotex mRNA Mini kit (Qiagen,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0445542:Mini [Organism Attribute]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C1998793:Purified [Functional Concept]
   748   C3273202:Kit [Manufactured Object]

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA)."
Processing 00000000.tx.43: Deoxyribonucleic acid was extracted by using Wizard Genomic DNA purification kit (Promega, Madison, MI). 

Phrase: "Deoxyribonucleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012854:Deoxyribonucleic Acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "extracted by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0185115:Extracted [Therapeutic or Preventive Procedure]
   833   C3541890:EXTRACTED [Finding]
   799 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Wizard Genomic DNA purification kit (Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "MI)."
Processing 00000000.tx.44: TissueBrain tissue was obtained at autopsy from clinically and pathologically confirmed cases of AD (n = 16) using National Institute of Aging and the Consortium to Establish a Registry for Alzheimers disease criteria (29), and was compared with tissue from non-demented, age, and postmortem interval-matched control cases (n = 16). 

Phrase: "TissueBrain tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "obtained at autopsy"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from clinically"

Phrase: "and"

Phrase: "pathologically confirmed cases of AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0521093:confirmed [Qualitative Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1456348:Confirm [Qualitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(n = 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "National Institute of Aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "the Consortium to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1513822:Consortium [Professional or Occupational Group]
   861   C1880171:Consortium [Professional or Occupational Group]

Phrase: "Establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a Registry for Alzheimers disease criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0920465:disease registry [Intellectual Product]
   753   C0034975:Registry [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "was"

Phrase: "compared with tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C1547928:Tissue [Intellectual Product]
   790   C1707455:Compared [Activity]

Phrase: "from non-demented, age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "postmortem interval-matched control cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "(n = 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: Hippocampal tissue was fixed in methacarn (methanol/chloroform/acetic acid, 60:30:10, by volume) at 4 C for 15 h. 

Phrase: "Hippocampal tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "fixed in methacarn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0066069:methacarn [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "(methanol/chloroform/acetic acid,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0000985:Acetic acid [Organic Chemical]
   839   C0220419:chloroformic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   756 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "60"

Phrase: ":"

Phrase: "30"

Phrase: ":"

Phrase: "10,"

Phrase: "by volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: ")"

Phrase: "at 4 C"

Phrase: "for 15 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.46: Following fixation, tissue was placed in 50% ethanol, dehydrated in an ascending ethanol series, and embedded in paraffin, and sections (6 m thick) were mounted onto silane-coated slides. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "fixation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Fixation [Therapeutic or Preventive Procedure]
  1000   C0728733:fixation [Mental Process]
  1000   C1522662:Fixation [Laboratory Procedure]

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "placed in 50% ethanol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001962:Ethanol [Organic Chemical]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "dehydrated in an ascending ethanol series,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0011175:Dehydrated [Disease or Syndrome]
   753   C0205385:Ascending [Qualitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C1547175:Ascending [Functional Concept]
   753   C1962987:Ascending [Functional Concept]
   753   C2348044:Series [Intellectual Product]
   719 E C0308355:ASCEND [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "embedded in paraffin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "(6 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "mounted onto silane-coated slides."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0178847:silane [Inorganic Chemical]
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0181909:Mount [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1705201:Slide [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.47: To assume that the mildly acidic nature of methacarn fixation does not alter metal ion binding to their tissue sites, some tissues were alternatively fixed in ethanol alone or left unfixed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assume"

Phrase: "that"

Phrase: "the mildly acidic nature of methacarn fixation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "metal ion binding to their tissue sites,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C1323274:Metal Ion Binding [Molecular Function]
           metal binding
   789   C1513163:Metal Binding Site [Amino Acid Sequence]
   778   C1752728:ion binding [Molecular Function]
   774   C0005456:Binding Sites [Receptor]
   757 E C0682969:Binding Site [Amino Acid Sequence]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "some tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "alternatively"

Phrase: "fixed in ethanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001962:Ethanol [Organic Chemical]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "left unfixed."
Processing 00000000.tx.48: No difference was seen between these preparation methods (30). 

Phrase: "No difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "seen between these preparation methods"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0939975:methods preparation [Qualitative Concept]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0205397:Seen [Qualitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C0871511:METHOD [Intellectual Product]
   726 E C1947903:See [Activity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.49: HistochemistryRedox staining was performed as previously published (30). 

Phrase: "HistochemistryRedox staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.50: In brief, following deparaffinization in xylene and hydration, sections were incubated in 3% H2O2 with 0.75 mg/ml DAB in 50 mM Tris/HCl, pH 7.6, for 2 h. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "deparaffinization in xylene"

Phrase: "and"

Phrase: "hydration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321013:Hydration [Finding]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated in 3% H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 0.75 mg/ml DAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086162:Dab [Food]
   804   C1081457:dab [Fish]

Phrase: "in 50 mM Tris/HCl,"

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.51: For comparative analyses, slides were processed simultaneously and incubated with DAB for identical intervals. 

Phrase: "For comparative analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0683941:comparative analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "and"

Phrase: "incubated with DAB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086162:Dab [Food]
   790   C1081457:dab [Fish]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for identical intervals."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.52: Iron(II) and iron(III) staining was performed by using an Iron(II)/Iron(III) detection kit (StressGen, British Colombia, Canada) following the manufacturer's direction. 

Phrase: "Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1550369:Performed By [Qualitative Concept]
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "/Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "detection kit (StressGen,"

Phrase: "British Colombia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009367:Colombia [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's direction."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]
Processing 00000000.tx.53: This iron detection method is a modification of the well established Prussian blue reaction (13). 

Phrase: "This iron detection method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449335:detection method [Intellectual Product]
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "a modification of the well established Prussian blue reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392747:Modification [Functional Concept]
   742   C1554963:modification [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.54: This method involves binding of iron(II) cyanide (ferrocyanide) to iron(III) (for detection of iron(III)) or iron(III) cyanide (ferricyanide) to iron(II) (for detection of iron(II)) to give a brilliant blue mixed-valence iron(II/III) complex, which can be observed directly or that can be enhanced, based on the ability of the mixed-valence complex to catalyze a peroxidase-like H2O2-dependent oxidation of DAB (13). 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "involves"

Phrase: "binding of iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1148613:binding iron [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "(II"

Phrase: ")"

Phrase: "cyanide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010505:Cyanide [Inorganic Chemical]

Phrase: "(ferrocyanide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062612:ferrocyanide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "to iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "("

Phrase: "for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ")"

Phrase: "or"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "cyanide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010505:Cyanide [Inorganic Chemical]

Phrase: "(ferricyanide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015864:ferricyanide [Inorganic Chemical]
  1000   C0117554:ferricyanide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "to iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "("

Phrase: "for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a brilliant blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054051:brilliant blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1260957:Blue [Qualitative Concept]

Phrase: "mixed-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "valence iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(II/III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: ","

Phrase: "based on the ability of the mixed-valence complex to"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   739   C0085732:Ability [Organism Attribute]
   739   C0205430:Mixed [Functional Concept]
   739   C0439855:Complex [Qualitative Concept]
   739   C1527178:Based [Functional Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
   739   C1705938:Based [Idea or Concept]
   739   C3160715:Mixed [Finding]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "a peroxidase-like H2O2-dependent oxidation of DAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030011:Oxidation [Molecular Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.55: The specificity of this reaction has been demonstrated by chelator or direct in situ catalysis of H2O2-mediated oxidation of DAB (13). 

Phrase: "The specificity of this reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated by chelator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1664784:Chelator [Eukaryote]

Phrase: "or"

Phrase: "direct in situ catalysis of H2O2-mediated oxidation of DAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0007382:Catalysis [Natural Phenomenon or Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.56: All treatments with nuclease or iron chelator were performed on adjacent serial sections. 

Phrase: "All treatments with nuclease"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "iron chelator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2266987:Iron Chelator [Pharmacologic Substance]
   861   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C1664784:Chelator [Eukaryote]

Phrase: "were"

Phrase: "performed on adjacent serial sections."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0031082:serial [Intellectual Product,Manufactured Object]
   760   C0205117:Adjacent [Spatial Concept]
   760   C0884358:Performed [Functional Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.57: For nuclease treatments, tissue sections were incubated with 1 mg/ml DNase I (Sigma) or 1 mg/ml RNase A (Sigma) overnight at 37 C. 

Phrase: "For nuclease treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with 1 mg/ml DNase I"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   778   C0439294:mg ml [Quantitative Concept]
   778   C1148702:DNase I [Genetic Function]
   774   C0268226:ML I [Disease or Syndrome]
   774   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   774   C1425233:I-1 [Gene or Genome]
   774   C3540559:I-1 [Gene or Genome]
   748   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "1 mg/ml RNase A (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "overnight at 37 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.58: For iron chelation, tissue sections were treated with 100 mM deferoxamine mesylate (Sigma) overnight at room temperature. 

Phrase: "For iron chelation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517598:Iron Chelation [Molecular Function]
   861   C3537131:Chelation [Molecular Function]

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "treated with 100 mM deferoxamine mesylate"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0011148:Deferoxamine Mesilate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0025619:Mesilate [Organic Chemical]
   753   C0066087:mesilate [Organic Chemical]
   753   C1522326:Treated [Functional Concept]
   753   C3645051:mesylate [Organic Chemical]
   734 E C0591350:Desferal [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "overnight at room temperature."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1547703:Room [Spatial Concept]
Processing 00000000.tx.59: Quantitation of CytochemistryImages were assessed by a Zeiss Axiocam digital camera (Carl Zeiss, Inc.) with a KS300 Imaging System quantitation program. 

Phrase: "Quantitation of CytochemistryImages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]

Phrase: "were"

Phrase: "assessed by a Zeiss Axiocam digital camera"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0179533:Camera [Medical Device]
   748   C0442015:Digital [Intellectual Product]
   748   C1516048:Assessed [Activity]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]
   748   C1883674:Digital [Qualitative Concept]

Phrase: "(Carl Zeiss,"

Phrase: "Inc.) with a KS300 Imaging System quantitation program."
Processing 00000000.tx.60: The intensity of the cytoplasmic reaction was evaluated by outlining manually and measuring the OD of the cytoplasm of neurons, excluding the nucleus, in three adjacent fields of the stratum pyramidal of the CA1 field of the hippocampus. 

Phrase: "The intensity of the cytoplasmic reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "evaluated by outlining manually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0220825:Evaluated [Functional Concept]

Phrase: "and"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the OD of the cytoplasm of neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0029421:OD [Disease or Syndrome]
   748   C0439164:OD [Quantitative Concept]
   748   C1512019:OD [Intellectual Product]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "in three adjacent fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   793   C1521738:Field [Conceptual Entity]
   793   C2346620:Field [Conceptual Entity]
   793   C2349184:Field [Conceptual Entity]
   793   C3539073:FIELD [Spatial Concept]

Phrase: "of the stratum"

Phrase: "pyramidal of the CA1 field of the hippocampus."
Processing 00000000.tx.61: To focus on cytoplasmic iron, neurons with NFT were excluded. 

Phrase: "To focus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focus [Spatial Concept]
  1000   C1285542:focus [Functional Concept]

Phrase: "on cytoplasmic iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "neurons with NFT"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.62: The OD measurement was obtained for each of the three fields and averaged. 

Phrase: "The OD measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "obtained for each of the three fields"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205449:Three [Quantitative Concept]
   748   C1301820:Obtained [Functional Concept]
   714   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   714   C1521738:Field [Conceptual Entity]
   714 E C1706701:Obtain [Activity]
   714   C2346620:Field [Conceptual Entity]
   714   C2349184:Field [Conceptual Entity]
   714   C3539073:FIELD [Spatial Concept]

Phrase: "and"

Phrase: "averaged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.63: The OD value was corrected for background by subtracting the OD of the neurophil on the same section. 

Phrase: "The OD value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "corrected for background"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176809:corrected for background [Qualitative Concept]
   790   C0205202:Corrected [Qualitative Concept]
   790   C1706907:Background [Conceptual Entity]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "by subtracting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: "the OD of the neurophil"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0029421:OD [Disease or Syndrome]
   760   C0439164:OD [Quantitative Concept]
   760   C1512019:OD [Intellectual Product]

Phrase: "on the same section."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]
Processing 00000000.tx.64: Measurements were done under the same optical and light conditions, and an electronic shading correction was used to compensate for unevenness arising in the illumination. 

Phrase: "Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "done under the same optical"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0445247:Same [Qualitative Concept]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]
   704   C0042789:Vision [Organism Function]
   704   C2707266:Vision [Clinical Attribute]

Phrase: "and"

Phrase: "light conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "an electronic shading correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705565:CORRECTION [Intellectual Product]
   827   C1947976:Correction [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compensate for unevenness arising"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205432:compensate [Qualitative Concept]
   770   C0332284:arising [Qualitative Concept]

Phrase: "in the illumination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023693:Illumination [Natural Phenomenon or Process]
  1000   C0023700:Illumination [Human-caused Phenomenon or Process]
  1000   C0684292:illumination [Laboratory Procedure]
  1000   C1964256:Illumination [Diagnostic Procedure]
Processing 00000000.tx.65: Dot Blot AnalysisUnless specifically mentioned in the following section, for analysis of redox-active iron binding, nucleic acid solutions were prepared at a concentration of 3.5 mg/ml in 0.1% diethylpyrocarbonate-treated water and 1 l of the solution per each dot was blotted on positive charged nylon membrane (Hybond-N+: Amersham Biosciences). 

Phrase: "Dot Blot AnalysisUnless specifically"

Phrase: "mentioned in the following section,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205155:Section [Spatial Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]

Phrase: "for analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of redox-active iron binding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1148613:iron binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "nucleic acid solutions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]
   734   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "prepared at a concentration of 3.5 mg/ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C2984062:mg/5 ml [Quantitative Concept]
   764   C0439294:mg ml [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   708   C1521827:Prepare [Functional Concept]

Phrase: "in 0.1% diethylpyrocarbonate-treated water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   804   C0599638:WATER [Substance]
   804   C1550678:Water [Inorganic Chemical]
   733 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "1 l of the solution"

Phrase: "per each dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "blotted on positive charged nylon membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0025255:Membrane [Tissue]
   753   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   753   C0439178:% Positive [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0740034:Nylon [Biomedical or Dental Material]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1706182:Membrane [Manufactured Object]
   753   C1706211:Charged [Organism Attribute]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "(Hybond-N+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: ":"

Phrase: "Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.66: Each dot blot analysis of RNA was done in triplicate. 

Phrase: "Each dot blot analysis of RNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C0005861:RNA blot analysis [Molecular Biology Research Technique]
   783   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "done in triplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
Processing 00000000.tx.67: Following UV fixation, the membrane was incubated in 0.01 mM ferrous chloride and 0.01 mM ferric citrate in 12.5 mM MES buffer, pH 6.6, for 1 h at room temperature with gentle rocking. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "UV fixation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0185023:Fixation [Therapeutic or Preventive Procedure]
   861   C0728733:fixation [Mental Process]
   861   C1522662:Fixation [Laboratory Procedure]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated in 0.01 mM ferrous chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0060275:ferrous chloride [Inorganic Chemical,Pharmacologic Substance]
   748   C0008203:Chloride, NOS [Inorganic Chemical]
   748   C0596019:Chloride [Element, Ion, or Isotope]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C2346592:Ferrous [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "0.01 mM ferric citrate in 12.5 mM MES buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0060231:ferric citrate [Inorganic Chemical]
   754   C3256468:citrate buffer [Pharmacologic Substance]
   738   C0008857:Citrate [Organic Chemical]
   738   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   738   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "pH 6.6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with gentle rocking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005899:Rocking [Individual Behavior]
Processing 00000000.tx.68: After rinsing with water, the membrane was incubated in 3% H2O2 with 0.75 mg/ml DAB in 50 mM Tris/HCl, pH 7.6, for 6 min at room temperature. 

Phrase: "After"

Phrase: "rinsing with water,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882955:Rinsing [Activity]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated in 3% H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 0.75 mg/ml DAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086162:Dab [Food]
   804   C1081457:dab [Fish]

Phrase: "in 50 mM Tris/HCl,"

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 6 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.69: Iron(II) and iron(III) staining was performed by the Iron(II)/Iron(III) detection kit (StressGen). 

Phrase: "Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed by the Iron"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C0884358:Performed [Functional Concept]
   770   C1166521:iron [Pharmacologic Substance]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "/Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "detection kit (StressGen"

Phrase: ")."
Processing 00000000.tx.70: The semi-solid phase reaction between iron and RNA in dot blot analysis simulates the condition between redox-active iron and RNA in tissue. 

Phrase: "The semi-solid phase reaction between iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "RNA in dot blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0005861:RNA blot analysis [Molecular Biology Research Technique]
   797   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "simulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "the condition between redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "RNA in tissue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.71: Because our finding of iron bound to RNA is based on this histochemical observation, we chose the dot blot approach to analyze our histochemical observations. 

Phrase: "Because"

Phrase: "our finding of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "bound to RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "is"

Phrase: "based on this histochemical observation,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1964257:Observation [Diagnostic Procedure]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "the dot blot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013064:dot blot [Laboratory Procedure]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "our histochemical observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.72: The blot image was captured immediately by using a scanner (Scan Jet 5370C; Hewlett Packard) and analyzed with the KS300 Imaging System quantitation program. 

Phrase: "The blot image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "captured"

Phrase: "immediately by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205548:Immediately [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a scanner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183115:scanner [Medical Device]
  1000   C1710020:Scanner [Medical Device]

Phrase: "(Scan Jet 5370C"

Phrase: "; Hewlett Packard"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed with the KS300 Imaging System quantitation program."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C2697665:Imaging System [Manufactured Object]
   744   C0011923:Imaging [Diagnostic Procedure]
   744   C0079595:Imaging [Diagnostic Procedure]
   744   C0449913:System [Functional Concept]
   744   C0936012:Analyzed [Research Activity]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1709697:Program [Conceptual Entity]
   744   C1709793:Quantitation [Quantitative Concept]
   744   C2728259:Program [Pharmacologic Substance]
   744   C3484370:Program [Functional Concept]
   711 E C1704254:Image [Intellectual Product]
   711 E C1704922:Image [Entity]
   711 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.73: The intensity of reaction was evaluated by measuring the mean OD of each dot outlined manually. 

Phrase: "The intensity of reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "evaluated by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0220825:Evaluated [Functional Concept]
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the mean OD of each dot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0029421:OD [Disease or Syndrome]
   753   C0439164:OD [Quantitative Concept]
   753   C1512019:OD [Intellectual Product]

Phrase: "outlined"

Phrase: "manually."
Processing 00000000.tx.74: The OD measurement was obtained for each of the three dots and averaged. 

Phrase: "The OD measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "obtained for each of the three dots"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0205449:Three [Quantitative Concept]
   748   C1301820:Obtained [Functional Concept]
   748   C1720485:Dots [Finding]
   714 E C0872145:DOT [Therapeutic or Preventive Procedure]
   714 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "averaged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.75: The OD value was corrected by subtracting the background OD. 

Phrase: "The OD value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "corrected by subtracting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205202:Corrected [Qualitative Concept]
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "the background OD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029421:OD [Disease or Syndrome]
   861   C0439164:OD [Quantitative Concept]
   861   C1512019:OD [Intellectual Product]
Processing 00000000.tx.76: In the case of the dot blot analysis for redox-active iron binding capacity in which different amounts of RNA were used, we assessed the sum of the OD area instead of the mean OD to measure the difference of iron binding when dot size varied. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the dot blot analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0013064:dot blot [Laboratory Procedure]

Phrase: "for redox-active iron binding capacity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0373658:Iron binding capacity [Laboratory Procedure]
   840   C0439155:Binding capacity [Quantitative Concept]
   840   C1148613:iron binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1145667:Binding [Activity]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1167622:Binding [Molecular Function]
   804   C1516240:Capacity [Quantitative Concept]

Phrase: "in which different amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the sum of the OD area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C3272913:Sum of Area [Quantitative Concept]
   753   C1515051:Sum [Quantitative Concept]

Phrase: "instead of the mean OD to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029421:OD [Disease or Syndrome]
   827   C0439164:OD [Quantitative Concept]
   827   C1512019:OD [Intellectual Product]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the difference of iron binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "when"

Phrase: "dot size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "varied."
Processing 00000000.tx.77: For detection of iron and redox activity in ribosomes from brain tissues, after adjusting the concentration of samples with ribosomal buffer (20 mM Tris/HCl, pH 7.4, 150 mM KCl, 5 mM MgCl2) each 1 l of sample was blotted on the nylon membrane and redox staining and iron(II)/iron(III) staining were performed as described above. 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "redox activity in ribosomes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1151028:redox activity [Molecular Function]
   833   C2266998:Redox Activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   767   C1752485:active ribosome [Cell Component]

Phrase: "from brain tissues,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0440746:brain tissues [Tissue]
   966 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissues [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "after"

Phrase: "adjusting"

Phrase: "the concentration of samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "with ribosomal buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20 mM Tris/HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM KCl,"

Phrase: "5 mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "each 1 l of sample"

Phrase: "was"

Phrase: "blotted on the nylon membrane"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "redox staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "were"

Phrase: "performed as described above."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.78: To correct for differences of redox-active iron binding to ribosomes because of the difference of the concentration of iron in brain homogenate, iron binding to ribosomes in the brain homogenate was also evaluated. 

Phrase: "To correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "of redox-active iron binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1148613:iron binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "to ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "because of the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "of the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "in brain homogenate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "iron binding to ribosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1148613:iron binding [Molecular Function]
   802   C1323391:ribosome binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "in the brain homogenate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "also"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.79: After adjusting the concentration of brain homogenate by the weight of brain tissue, we blotted 1 l of brain homogenate and examined iron(II), iron(III), and redox activity as mentioned. 

Phrase: "After"

Phrase: "adjusting"

Phrase: "the concentration of brain homogenate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "by the weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "of brain tissue,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "we"

Phrase: "blotted"

Phrase: "1 l of brain homogenate"

Phrase: "and"

Phrase: "examined iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: ","

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "mentioned."
Processing 00000000.tx.80: The OD of ribosome was divided by that of the brain homogenate corresponding to the ribosome sample and expressed as an arbitrary unit. 

Phrase: "The OD of ribosome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0029421:OD [Disease or Syndrome]
   770   C0439164:OD [Quantitative Concept]
   770   C1512019:OD [Intellectual Product]

Phrase: "was"

Phrase: "divided by that of the brain homogenate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0332849:Divided [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "corresponding to the ribosome sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035553:Ribosome [Cell Component]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   760   C2984240:Ribosome [Functional Concept]

Phrase: "and"

Phrase: "expressed as an arbitrary unit."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0439183:Arbitrary unit [Quantitative Concept]
   760   C0439148:Unit [Quantitative Concept]
   760   C1264693:*Arbitrary [Quantitative Concept]
   760   C1519795:Unit [Quantitative Concept]
   760   C1704753:Unit [Manufactured Object]
   760   C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.81: For treatment of ribosome with proteinase K or RNase, the dotted membrane was incubated with 1 g/ml proteinase K or 1 mg/ml RNase A at 37 C for 2 h in Tris-buffered saline, pH 7.6. 

Phrase: "For treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of ribosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035553:Ribosome [Cell Component]
  1000   C2984240:Ribosome [Functional Concept]

Phrase: "with proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1708601:K' [Quantitative Concept]
   861   C1947941:Proteinase [Enzyme]

Phrase: "or"

Phrase: "RNase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the dotted membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with 1 g/ml proteinase K"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1300565:g/mL [Quantitative Concept]
   774   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1622131:proteinase [Molecular Function]
   748   C1708601:K' [Quantitative Concept]
   748   C1947941:Proteinase [Enzyme]

Phrase: "or"

Phrase: "1 mg/ml RNase A at 37 C"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.6."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.82: To detect 8-OHG in RNA, 5 g of RNA samples were dot blotted on the positive charged nylon membrane (Hybond-N+). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "8-OHG in RNA,"

Phrase: "5 g of RNA samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "blotted on the positive charged nylon membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0025255:Membrane [Tissue]
   748   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0740034:Nylon [Biomedical or Dental Material]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C1706182:Membrane [Manufactured Object]
   748   C1706211:Charged [Organism Attribute]
   748   C2825490:Positive [Qualitative Concept]

Phrase: "(Hybond-N+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: ")."
Processing 00000000.tx.83: Following UV fixation, the membrane was incubated with 10% nonfat dry milk in Tris-buffered saline, pH 7.6, for 1 h at room temperature. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "UV fixation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0185023:Fixation [Therapeutic or Preventive Procedure]
   861   C0728733:fixation [Mental Process]
   861   C1522662:Fixation [Laboratory Procedure]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with 10% nonfat dry milk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0011682:Dry [Natural Phenomenon or Process]
   753   C0026131:Milk [Body Substance]
   753   C0205222:Dry [Qualitative Concept]
   753   C0349374:Milk [Food]
   753   C0444318:Milk [Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1512080:Dry [Qualitative Concept]
   753   C2825079:Milk [Food]

Phrase: "in Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.84: The membrane was incubated with the monoclonal antibody 15A3 (1:500; 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with the monoclonal antibody 15A3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.85: QED Bioscience, San Diego, CA) overnight at 4 C and then incubated with a secondary peroxidase-conjugated goat anti-mouse antibody. 

Phrase: "QED Bioscience,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA) overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with a secondary peroxidase-conjugated goat anti-mouse antibody."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0018019:goat [Mammal]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0027627:secondary [Neoplastic Process]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0175668:Secondary [Temporal Concept]
   739   C0205436:Secondary [Quantitative Concept]
   739   C0522529:Conjugated [Spatial Concept]
   739   C1265549:goat [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1510458:Goat [Mammal]
Processing 00000000.tx.86: The specificity of the anti-8-OHG monoclonal antibody on immunocytochemistry, Northwestern blot, and immunoprecipitation has been reported (5, 31). 

Phrase: "The specificity of the anti-8-OHG monoclonal antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0003264:Antibody Specificity [Molecular Function]
   742   C0037791:Specificity [Quantitative Concept]
   742   C1511884:Specificity [Quantitative Concept]
   726 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "on immunocytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "Northwestern blot,"

Phrase: "and"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: In the present study, we also confirmed its specificity by antigen absorption with excess 8-OHG and omission of this antibody on immunoprecipitation (details presented under "Immunoprecipitation" below). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we also"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "its specificity by antigen absorption"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1536991:antigen specificity [Molecular Function]
   762 E C0003317:Antigenic Specificity [Natural Phenomenon or Process]
   762 E C0456981:Specific antigen [Immunologic Factor]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "with excess 8-OHG"

Phrase: "and"

Phrase: "omission of this antibody"

Phrase: "on immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "presented under ""Immunoprecipitation"""
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "below"

Phrase: ")."
Processing 00000000.tx.88: Additionally, we found increased RNA oxidation in AD brain by analytical analysis of nucleic acids.2 The signals were detected with ECL (Santa Cruz) according to the manufacturer's direction and the image was digitally captured. 

Phrase: "Additionally,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "increased RNA oxidation in AD brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "by analytical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of nucleic acids.2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0001128:Acids [Chemical]
   827   C0007610:Nucleic [Cell Component]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "The signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected with ECL (Santa Cruz"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C1332684:ECL [Gene or Genome]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "according to the manufacturer's direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]

Phrase: "and"

Phrase: "the image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "digitally"

Phrase: "captured."
Processing 00000000.tx.89: Optical density was analyzed with a KS300 Imaging System as stated above. 

Phrase: "Optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed with a KS300 Imaging System"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C2697665:Imaging System [Manufactured Object]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0449913:System [Functional Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "as stated above."
Processing 00000000.tx.90: Oxidation of RNA by the Fenton ReactionTwo hundred l of RNA sample was incubated in an iron solution (200 M FeCl2 and 200 M ferric citrate in 12.5 mM MES buffer, pH 6.6) at 4 C for 5 min and then hydrogen peroxide (10 mM final concentration) was added. 

Phrase: "Oxidation of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "by the Fenton ReactionTwo hundred l"

Phrase: "of RNA sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "incubated in an iron solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037633:Solution [Substance]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(200 M FeCl2"

Phrase: "and"

Phrase: "200 M ferric citrate in 12.5 mM MES buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0060231:ferric citrate [Inorganic Chemical]
   757   C3256468:citrate buffer [Pharmacologic Substance]
   739   C0008857:Citrate [Organic Chemical]
   739   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   739   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "pH 6.6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 4 C"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0020275:Hydrogen [Element, Ion, or Isotope]
   827   C0031180:Peroxide [Inorganic Chemical]
   827   C0523702:HYDROGEN [Laboratory Procedure]
   827   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(10 mM final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.91: After incubation for 30 min at 37 C, the reaction was terminated with deferoxamine (10 mM final concentration) and chilled on ice for 5 min. 

Phrase: "After incubation"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C,"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated with deferoxamine"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1553404:terminated [Idea or Concept]
   790   C2348570:Terminated [Functional Concept]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "(10 mM final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "and"

Phrase: "chilled on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0085593:Chill [Sign or Symptom]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.92: The oxidized RNA was precipitated with 3 M sodium acetate, pH 5.2, and 100% ethanol. 

Phrase: "The oxidized RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "precipitated with 3 M sodium acetate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   753   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   719   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "pH 5.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "100% ethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]
Processing 00000000.tx.93: The pellet was washed with 75% ethanol and dried for 5 min. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed with 75% ethanol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0001962:Ethanol [Organic Chemical]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "dried for 5 min."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   770   C1512080:Dried [Qualitative Concept]
   770   C2827485:Dried [Body Substance]
   737 E C0011682:Dry [Natural Phenomenon or Process]
   737 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.94: It was resuspended in 20 l of 0.1% diethylpyrocarbonate-treated water. 

Phrase: "It"

Phrase: "was"

Phrase: "resuspended in 20 l of 0.1% diethylpyrocarbonate-treated water."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   739   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   739   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   739   C0332293:treated [Therapeutic or Preventive Procedure]
   739   C0599638:WATER [Substance]
   739   C1522326:Treated [Functional Concept]
   739   C1550678:Water [Inorganic Chemical]
   706 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.95: Northwestern BlottingFollowing oxidization, 20 g of an RNA sample was electrophoresed in 1.2% agarose/formaldehyde gels and capillary-transferred onto positive charged nylon membrane. 

Phrase: "Northwestern BlottingFollowing oxidization,"

Phrase: "20 g of an RNA sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "electrophoresed in 1.2% agarose/formaldehyde gels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C1706746:Agarose Gel [Research Device]
   748   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   714   C0013855:electrophorese [Laboratory Procedure]
   714 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "capillary-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006901:Capillary [Body Part, Organ, or Organ Component]
  1000   C0935624:Capillary [Body Part, Organ, or Organ Component]
  1000   C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "transferred onto positive charged nylon membrane."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   753   C0025255:Membrane [Tissue]
   753   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   753   C0348011:transferred [Functional Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0740034:Nylon [Biomedical or Dental Material]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1706182:Membrane [Manufactured Object]
   753   C1706211:Charged [Organism Attribute]
   753   C2825490:Positive [Qualitative Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]
Processing 00000000.tx.96: The membrane was treated in the same manner as the dot blot analysis. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "treated in the same manner"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0445247:Same [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "as the dot blot analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0013064:dot blot [Laboratory Procedure]
Processing 00000000.tx.97: The image was exposed to x-ray film (Kodak, Rochester, NY). 

Phrase: "The image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "exposed to x-ray film"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0043303:X-Ray Film [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
   760   C2314876:ray [Fish]

Phrase: "(Kodak,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: Electron MicroscopyUltrastructural localization of redox activity with DAB was performed with tissue from a 75-year-old AD patient with a postmortem interval of 4 h. 

Phrase: "Electron MicroscopyUltrastructural localization of redox activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "with DAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086162:Dab [Food]
  1000   C1081457:dab [Fish]

Phrase: "was"

Phrase: "performed with tissue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C0884358:Performed [Functional Concept]
   790   C1547928:Tissue [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from a 75-year-old AD patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with a postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: "of 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.99: The tissue was fixed in 2% paraformaldehyde, 0.5% glutaraldehyde, 0.5 mM calcium chloride, 0.1 M sodium cacodylate, pH 7.4. 

Phrase: "The tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "fixed in 2% paraformaldehyde,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "0.5% glutaraldehyde,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   771 E C0878318:Cidex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.5 mM calcium chloride,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0006686:Calcium Chloride [Inorganic Chemical,Pharmacologic Substance]
   804   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0006726:Calcium [Inorganic Chemical]
   804   C0008203:Chloride, NOS [Inorganic Chemical]
   804   C0596019:Chloride [Element, Ion, or Isotope]
   804   C2936886:Calcium [Pharmacologic Substance]

Phrase: "0.1 M sodium cacodylate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0300984:Sodium cacodylate [Organic Chemical]
   804   C0282083:Cacodylate [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.100: After extensive washing in phosphate-buffered saline, the section was incubated in 100% normal goat serum, followed by rabbit anti-serum to DAB (gift of Dr. B. Erlanger, Department of Pathology, Columbia University, New York) (32) for 16 h at 4 C. 

Phrase: "After extensive washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "in phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "incubated in 100% normal goat serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0018019:goat [Mammal]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0439166:% normal [Quantitative Concept]
   753   C1265549:goat [Mammal]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1510458:Goat [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "followed by rabbit anti-serum"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0034493:Rabbit [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "to DAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086162:Dab [Food]
  1000   C1081457:dab [Fish]

Phrase: "(gift of Dr. B. Erlanger,"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Columbia University,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ")"

Phrase: "(32"

Phrase: ")"

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.101: Following rinsing, 17-nm gold-labeled goat antiserum to rabbit IgG was applied. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "rinsing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882955:Rinsing [Activity]

Phrase: "17-nm gold-labeled goat antiserum to rabbit IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.102: The tissue was fixed in 2.5% glutaraldehyde and then post-fixed in 1.0% OsO4. 

Phrase: "The tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "fixed in 2.5% glutaraldehyde"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]
   704 E C0878318:Cidex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "post-fixed in 1.0% OsO4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
   753   C2827483:Fixed [Body Substance]
Processing 00000000.tx.103: The specimens were dehydrated and embedded in Spurrs medium, sectioned at 60100 nm, and contrasted with lead and uranyl salts. 

Phrase: "The specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: "and"

Phrase: "embedded in Spurrs medium,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C1707903:Embedded [Laboratory Procedure]
   770   C3244283:medium [Intellectual Product]

Phrase: "sectioned at 60100 nm,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0312860:NM [Cell Function]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "contrasted with lead"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0449900:contrasted [Diagnostic Procedure]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   756 E C1979874:Contrast [Qualitative Concept]
   706 E C0181586:leads [Medical Device]

Phrase: "and"

Phrase: "uranyl salts."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.104: The specimens were examined in a Zeiss CEM 902 electron microscope at 80 kV. 

Phrase: "The specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "examined in a Zeiss CEM 902 electron microscope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0181845:Electron Microscope [Medical Device]
   744   C0013852:Electron [Quantitative Concept]
   744   C0181839:Microscope [Medical Device]
   744   C0332128:Examined [Finding]
   744   C1706379:Microscope [Medical Device]
   744   C3463986:Electron [Bird]

Phrase: "at 80 kV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556639:kV [Quantitative Concept]
Processing 00000000.tx.105: View larger version (102K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(102K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.106: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.107: Redox activity is increased in CA1 pyramidal neurons in AD. 

Phrase: "Redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "increased in CA1 pyramidal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "in AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.108: A, tissue sections of hippocampus from AD and age-/PMI-matched control brains (control, n = 5; AD, n = 6) were examined by redox staining. 

Phrase: "A,"

Phrase: "tissue sections of hippocampus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C2316368:Tissue section [Tissue]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "from AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "age-/PMI-matched control brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0006104:Brains [Body Part, Organ, or Organ Component]
   771 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "examined by redox staining."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030012:Redox [Molecular Function]
   770   C0332128:Examined [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.109: The intensity of redox staining of pyramidal neurons in three fields of the CA1 region were analyzed in digitally captured images. 

Phrase: "The intensity of redox staining of pyramidal neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522510:Intensity [Qualitative Concept]

Phrase: "in three fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C3539073:FIELD [Spatial Concept]

Phrase: "of the CA1 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "analyzed in digitally captured images."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0936012:Analyzed [Research Activity]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]
Processing 00000000.tx.110: AD cases show significantly higher levels of redox activity (S.E.) in CA1 pyramidal neurons than controls (p = 0.0021). 

Phrase: "AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "significantly higher levels of redox activity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   783   C0683317:activity levels [Finding]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "S."

Phrase: "E.) in CA1 pyramidal neurons"

Phrase: "than controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(p = 0.0021"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.111: B, redox staining of the cytoplasm from a representative case of AD was diminished by RNase A treatment, but DNase I treatment of serial sections had little effect in the cytoplasm or nucleus. 

Phrase: "B,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "redox staining of the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "from a representative case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "diminished by RNase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0205216:Diminished [Quantitative Concept]

Phrase: "A treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "but"

Phrase: "DNase I treatment of serial sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "little effect in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.112: C, pretreatment with deferoxamine considerably decreased the redox staining of the cytoplasm. 

Phrase: "C,"

Phrase: "pretreatment with deferoxamine considerably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the redox staining of the cytoplasm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
Processing 00000000.tx.113: Scale bar = 10 m.  

Phrase: "Scale bar = 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.114: Preparation of RibosomesHippocampus from postmortem brain (about 2 g) was homogenized by using a glass homogenizer (pestle A 10 times then pestle B 10 times) in 9 ml of ice-cold ribosomal buffer containing 30 units/ml of RNase inhibitor (Roche Diagnostics, Indianapolis, IN). 

Phrase: "Preparation of RibosomesHippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "from postmortem brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(about 2 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "homogenized by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glass homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]

Phrase: "(pestle A 10 times then pestle B 10 times"

Phrase: ")"

Phrase: "in 9 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of ice-cold ribosomal buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "30 units/ml of RNase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C2945590:unit/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.115: The homogenate was centrifuged at 13,000 x g (Beckman JA20) for 10 min at 4 C. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 13,000 x g (Beckman JA20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439267:g% [Quantitative Concept]
   711   C0179834:centrifuge [Medical Device]

Phrase: ")"

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.116: The supernatant (1 ml) was transferred onto a 1540% sucrose gradient (11.5 ml) and then centrifuged at 35,000 x g (Beckman SW 40Ti) for 2 h at 4 C. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(1 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "transferred onto a 1540% sucrose gradient"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0348011:transferred [Functional Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(11.5 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 35,000 x g (Beckman SW 40Ti"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0439267:g% [Quantitative Concept]
   742   C1420193:SW [Gene or Genome]
   742   C1832169:SW [Body System]
   742   C3538902:SW [Gene or Genome]
   708   C0179834:centrifuge [Medical Device]

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.117: Optical density at 254 nm was measured using a UA-5 UV detector (ISCO) and fractions containing monosomes were collected. 

Phrase: "Optical density at 254 nm"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0439164:Optical density [Quantitative Concept]
   806   C1268822:Optical density [Clinical Attribute]
   760   C0178587:density [Quantitative Concept]
   704   C0042789:Vision [Organism Function]
   704   C2707266:Vision [Clinical Attribute]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a UA-5 UV detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0180392:Detector [Medical Device]
   812   C1705235:Detector [Manufactured Object]

Phrase: "(ISCO"

Phrase: ")"

Phrase: "and"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "monosomes"

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.118: The fractions were transferred onto a 1 M sucrose cushion and centrifuged at 45,000 x g (Beckman 50Ti) for20 h at 4 C. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "transferred onto a 1 M sucrose cushion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0180249:cushion [Medical Device]
   748   C0348011:transferred [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   714 E C0040671:Transfer [Mental Process]
   714 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "centrifuged at 45,000 x g (Beckman 50Ti"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439267:g% [Quantitative Concept]
   711   C0179834:centrifuge [Medical Device]

Phrase: ")"

Phrase: "for20 h at 4 C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.119: The pellet was reconstituted with 0.1% diethylpyrocarbonate-treated water and stored at 80 C. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "reconstituted with 0.1% diethylpyrocarbonate-treated water"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   774   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0599638:WATER [Substance]
   748   C1522326:Treated [Functional Concept]
   748   C1550678:Water [Inorganic Chemical]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "stored at 80 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]
Processing 00000000.tx.120: View larger version (93K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(93K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.122: Iron(II) staining is increased in CA1 pyramidal neurons in AD. 

Phrase: "Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "increased in CA1 pyramidal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "in AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.123: Visualization of iron(II) localized in neuronal cytoplasm. 

Phrase: "Visualization of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0175631:Visualization [Mental Process]
   790   C2827662:Visualization [Occupation or Discipline]

Phrase: "(II"

Phrase: ")"

Phrase: "localized in neuronal cytoplasm."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1178979:Neuron cytoplasm [Cell Component]
   770   C0010834:Cytoplasm [Cell Component]
   770   C0392752:Localized [Spatial Concept]
   770   C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.124: Note the extensive iron staining in the cytoplasm and nucleus of AD brains (B), whereas it remains at low levels in controls (A). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the extensive iron staining in the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0200676:iron staining [Laboratory Procedure]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "nucleus of AD brains (B),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1706993:Nucleus of brain [Body Part, Organ, or Organ Component]
           Brain nucleus
   760   C0007610:Nucleus [Cell Component]

Phrase: "whereas"

Phrase: "it"

Phrase: "remains at low levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.125: The intensity of iron(II) staining expressed as mean density ( S.E.) was analyzed. 

Phrase: "The intensity of iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "expressed as mean density"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178587:density [Quantitative Concept]
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "("

Phrase: "S."

Phrase: "E.)"

Phrase: "was"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.126: Note there is a significant difference between AD and age-matched control brains (p = 0.0001). 

Phrase: "Note there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1316572:Note [Clinical Attribute]
   861   C1317574:Note [Intellectual Product]
   861   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "a significant difference between AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "age-matched control brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(p = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.127: C, cytoplasmic iron(II) staining (D) from a case of AD is almost completely removed with RNase treatment (E), but no apparent change was observed with DNase treatment (F). 

Phrase: "C,"

Phrase: "cytoplasmic iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "D) from a case of AD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]

Phrase: "is"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "removed with RNase treatment"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0849355:Removed [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "(E"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "no apparent change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed with DNase treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.128: Scale bar = 10 m.  

Phrase: "Scale bar = 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.129: In Vitro TranslationThe poly(U) assay was performed as previously published (33, 34). 

Phrase: "In Vitro TranslationThe poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.130: After oxidation of ribosomes from rabbit reticulocytes, 0.4 A260 units of ribosomes was used as a component in the following 50-l reaction mixture (100 mM KCl, 20 mM Tris/HCl, pH 7.5, 1.0 mM GTP, 2.1 mM phosphoenolpyruvate, 0.3 IU of pyruvate kinase, 1.0 mM dithiothreitol, 10 mM MgCl2, 0.2 A260 units of poly(U), 10 pmol of [14C]Phe-tRNA, and saturating levels of 2 g of eEF-1A and 0.2 gof eEF-2). 

Phrase: "After oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "from rabbit reticulocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035286:Reticulocytes [Cell]

Phrase: "0.4 A260 units of ribosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "was"

Phrase: "used as a component"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0449432:Component [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1705248:Component [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in the following 50-l reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439962:Mixture [Substance]

Phrase: "(100 mM KCl,"

Phrase: "20 mM Tris/HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1.0 mM GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2.1 mM phosphoenolpyruvate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031642:Phosphoenolpyruvate [Biologically Active Substance,Organophosphorus Compound]

Phrase: "0.3 IU of pyruvate kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439453:IU [Quantitative Concept]

Phrase: "1.0 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "10 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.2 A260 units of poly(U"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0439148:Units [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "10 pmol of [14C"

Phrase: "]Phe-tRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "saturating levels of 2 g of eEF-1A"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "0.2 gof eEF-2"

Phrase: ")."
Processing 00000000.tx.131: The reaction mixtures are incubated at 37 C for 5 min, and the reaction was terminated by the addition of 1 ml of cold 10% trichloroacetic acid. 

Phrase: "The reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "are"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by the addition of 1 ml of cold 10% trichloroacetic acid."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   736   C0001128:Acid [Chemical]
   736   C0009264:Cold [Natural Phenomenon or Process]
   736   C0009443:Cold [Disease or Syndrome]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0234192:Cold [Physiologic Function]
   736   C0439526:/mL [Quantitative Concept]
   736   C1553404:terminated [Idea or Concept]
   736   C1883712:Addition [Functional Concept]
   736   C2348570:Terminated [Functional Concept]
Processing 00000000.tx.132: Then the reaction tubes were heated at 90 C for 15 min. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the reaction tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "heated at 90 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.133: Precipitated proteins were collected by vacuum filtration onto nitrocellulose filters (Millipore, Bedford, MA). 

Phrase: "Precipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "collected by vacuum filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016107:filtration [Laboratory Procedure]
   770   C0042221:Vacuum [Natural Phenomenon or Process]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "onto nitrocellulose filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0180860:Filters [Manufactured Object]
   827 E C0581406:Filter [Medical Device]
   827 E C1522664:Filter [Intellectual Product]
   827 E C1704449:Filter [Conceptual Entity]
   827 E C1704684:Filter [Medical Device]
   827 E C1875155:FILTER [Medical Device]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.134: Radioactivity was determined by liquid scintillation spectrometry. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined by liquid scintillation spectrometry."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0597425:scintillation spectrometry [Diagnostic Procedure]
   760   C0302908:Liquid [Substance]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.135: ImmunoprecipitationRibosomal RNA (1.5 g) that was purified from the ribosomes were incubated with 2.5 g of anti-8-OHG antibody 15A3 at 4 C for 1 h. 

Phrase: "ImmunoprecipitationRibosomal RNA (1.5 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "purified from the ribosomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0035553:Ribosomes [Cell Component]
   770   C1998793:Purified [Functional Concept]
   737 E C2984240:Ribosome [Functional Concept]

Phrase: "were"

Phrase: "incubated with 2.5 g of anti-8-OHG antibody 15A3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0439267:g% [Quantitative Concept]
   738   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4 C"

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.136: The integrity and quality of rRNA were confirmed for each sample by gel analysis and spectrophotometry. 

Phrase: "The integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "quality of rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332306:Quality [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed for each sample"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0370003:Sample [Substance]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "by gel analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "spectrophotometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037805:Spectrophotometry [Laboratory Procedure]
Processing 00000000.tx.137: A260/A280 of each sample fell into the range from 1.8 to 2.0. 

Phrase: "A260/A280 of each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706689:A280 [Molecular Biology Research Technique]

Phrase: "fell into the range"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]
   737   C0085639:Fall [Finding]
   737   C0238715:Fall [Temporal Concept]

Phrase: "from 1.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "to 2.0."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]
Processing 00000000.tx.138: To further confirm the purity of rRNA, we examined the presence of mRNA with poly(A) tails in the purified rRNA samples by using an Oligotex mRNA kit (Qiagen). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the purity of rRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882508:Purity [Quantitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the presence of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "tails in the purified rRNA samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0039259:Tails [Body Part, Organ, or Organ Component]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Oligotex mRNA kit (Qiagen"

Phrase: ")."
Processing 00000000.tx.139: mRNA was not detected in the samples from AD or controls. 

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in the samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.140: For negative controls, the primary antibody was omitted or preincubated with 24 ng/l of 8-OHG (Cayman Chemical, Ann Arbor, MI). 

Phrase: "For negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]

Phrase: "or"

Phrase: "preincubated with 24 ng/l of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439297:ng/L [Quantitative Concept]

Phrase: "(Cayman Chemical, Ann Arbor,"

Phrase: "MI)."
Processing 00000000.tx.141: Protein G Plus-agarose (20 l) (Santa Cruz Biotechnology, Santa Cruz, CA) was added and incubated with gentle rotation overnight at 4 C. 

Phrase: "Protein G Plus-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "(20 l) (Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated with gentle rotation overnight"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035868:Rotation [Functional Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C0677597:Rotation [Functional Concept]
   760   C0720654:Gentle [Organic Chemical,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4 C."
Processing 00000000.tx.142: The beads were washed three times with phosphate-buffered saline, pH 7.4, and 0.04% (v/v) Nonidet P-40 (Roche). 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with phosphate-buffered saline,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "0.04%"

Phrase: "(v/v) Nonidet P-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   875   C1535597:v p [Therapeutic or Preventive Procedure]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.143: Then the following reagents were added subsequently: 300 l of phosphate-buffered saline with 0.04% Nonidet P-40, 30 l of 10% (w/v) SDS, and 300 l of phenol/chloroform solution. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the following reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "subsequently"

Phrase: ":"

Phrase: "300 l of phosphate-buffered saline"

Phrase: "with 0.04% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "30 l of 10%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "SDS,"

Phrase: "and"

Phrase: "300 l of phenol/chloroform solution."
Processing 00000000.tx.144: The mixture was incubated at 37 C for 15 min (vortexed every 5 min) and separated into an aqueous phase and an organic phase by centrifugation at 14,000 x g for 5 min. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 15 min ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "every 5 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "separated into an aqueous phase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0599956:Aqueous [Qualitative Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "an organic phase by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205390:Phase [Temporal Concept]

Phrase: "at 14,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.145: The aqueous phase was transferred to a new tube and mixed with 30 lof3 M sodium acetate, pH 5.2, 2 l of 5 mg/ml glycogen, plus 750 l of ethanol. 

Phrase: "The aqueous phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "transferred to a new tube"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0175730:Tube [Medical Device]
   760   C0205314:New [Temporal Concept]
   760   C0348011:transferred [Functional Concept]
   760   C1547937:Tube NOS [Intellectual Product]
   760   C1561954:tube [Conceptual Entity]
   760   C1704730:TUBE [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "mixed with 30 lof3 M sodium acetate,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0205430:Mixed [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]

Phrase: "pH 5.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2 l of 5 mg/ml glycogen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0439268:mg/L [Quantitative Concept]
   774   C1635169:mL/L [Quantitative Concept]

Phrase: "plus 750 l of ethanol."
Processing 00000000.tx.146: The sample was frozen at 80 C for 1 h and centrifuged for 20 min. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "frozen at 80 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0677542:Frozen [Functional Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged for 20 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]
Processing 00000000.tx.147: The sample was washed with 75% (v/v) ethanol and air-dried. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "washed with 75%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "(v/v) ethanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001962:Ethanol [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "air-dried."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.148: It was reconstituted with 15 l of diethylpyrocarbonate-treated water. 

Phrase: "It"

Phrase: "was"

Phrase: "reconstituted with 15 l of diethylpyrocarbonate-treated water."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   744   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   744   C0599638:WATER [Substance]
   744   C1522326:Treated [Functional Concept]
   744   C1550678:Water [Inorganic Chemical]
   711 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.149: Reverse Transcription and Polymerase Chain ReactionImmunoprecipitated rRNA was reverse transcribed to cDNA using a Retroscript kit (Ambion, Austin, TX) according to the manufacturer's directions, and then PCR was performed with specific primers and DNA polymerase (Ambion). 

Phrase: "Reverse Transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "Polymerase Chain ReactionImmunoprecipitated rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed to cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Retroscript kit (Ambion,"

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "TX) according to the manufacturer's directions,"

Phrase: "and"

Phrase: "then PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with specific primers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1552740:specific [Intellectual Product]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Ambion"

Phrase: ")."
Processing 00000000.tx.150: The following primers specific for human 28 S and 18 S rRNA were used: 28 S forward, 5'-CGGATTCCGACTTCCATG-3' (nt 16351653: Gen-BankTM accession M11167 [GenBank] ), reverse, 5'-TGGTTCCCTCCGAAGTTTC-3' (nt 19731956); 

Phrase: "The following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for human 28 S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "18 S rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "28 S"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ","

Phrase: "5'-CGGATTCCGACTTCCATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(nt 16351653"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: ":"

Phrase: "Gen-BankTM accession M11167"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "reverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "5'-TGGTTCCCTCCGAAGTTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(nt 19731956"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.151: 18 S forward, 5'-CCCGAGATTGAGCAATAA-3' (nt 14701487 GenBank accession X03205 [GenBank] ), reverse, 5'-GCCTCACTAAACCATCCAA-3' (nt 17381720). 

Phrase: "18 S"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ","

Phrase: "5'-CCCGAGATTGAGCAATAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(nt 14701487 GenBank accession X03205"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "reverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "5'-GCCTCACTAAACCATCCAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(nt 17381720"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.152: The PCR conditions were 30 cycles of 94 C for 30 s, 55 C for 30 s, and 72 C for 40 s. 

Phrase: "The PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "30 cycles of 94 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "55 C for 30 s,"

Phrase: "and"

Phrase: "72 C for 40 s."
Processing 00000000.tx.153: PCR products were examined on a 2% agarose gel stained with ethidium bromide.  

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "examined on a 2% agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C0332128:Examined [Finding]
   753   C1382104:Gel [Substance]

Phrase: "stained with ethidium bromide."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.154: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In Situ Redox Activity and Redox-active Iron Are Associated with Cytoplasmic RNA in ADWe quantified the intensity of DAB staining in neuronal cytoplasm at the CA1 area in AD (n = 6), and age- and PMI-matched control cases (n = 5) (mean age (year)  S.D.: 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "In Situ Redox Activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1151028:redox activity [Molecular Function]
   861   C2266998:Redox Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Redox-active Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "Are"

Phrase: "Associated with Cytoplasmic RNA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2827481:Cytoplasmic RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0010834:Cytoplasmic [Cell Component]
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521449:Cytoplasmic [Body Location or Region]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in ADWe"

Phrase: "quantified"

Phrase: "the intensity of DAB staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "in neuronal cytoplasm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "at the CA1 area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "PMI-matched control cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(mean age (year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.155: AD 73.83  6.68; 

Phrase: "AD 73.83  6.68"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   885   C1854187:Alzheimer Disease 6 [Disease or Syndrome]
   830   C0048433:MAL-6 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0450387:68 [Intellectual Product]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.156: control: 67.8  7.05; 

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "67.8  7.05"

Phrase: ";"
Processing 00000000.tx.157: mean PMI (hour)  S.D.: 

Phrase: "mean PMI (hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439227:Hour [Temporal Concept]
   827   C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.158: AD 13.17  9.22, control: 16.36  7.19). 

Phrase: "AD 13.17  9.22,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   885   C1837149:Alzheimer Disease 9 [Disease or Syndrome]
   867   C3554452:ALZHEIMER DISEASE 17 [Disease or Syndrome]
   861   C1970147:Alzheimer Disease 13 [Disease or Syndrome]
   839   C0450332:17/22 [Quantitative Concept]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "16.36  7.19"

Phrase: ")."
Processing 00000000.tx.159: We observed a significantly higher level of redox activity in AD than control (p = 0.0021) (Fig. 1A). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significantly higher level of redox activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0683317:Activity level [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "than control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(p = 0.0021"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.160: Because this result is similar to that of cytoplasmic RNA oxidation of CA1 pyramidal neurons in AD (5), we examined the effect of RNase on redox staining. 

Phrase: "Because"

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "similar to that of cytoplasmic RNA oxidation of CA1 pyramidal neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2348205:Similar [Qualitative Concept]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of RNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on redox staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.161: Pretreatment with RNase A essentially abolished redox staining in CA1 pyramidal neuron cytoplasm, whereas treatment with DNase I had no significant effect, suggesting the association of redox activity with RNA in the neuronal cytoplasm (Fig. 1B). 

Phrase: "Pretreatment with RNase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "A essentially abolished redox staining in CA1 pyramidal neuron cytoplasm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0487602:Staining [Laboratory Procedure]
   739   C1704680:Staining [Finding]

Phrase: "whereas"

Phrase: "treatment with DNase I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "no significant effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the association of redox activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the neuronal cytoplasm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: The iron chelator deferoxamine almost completely abolished cytoplasmic redox staining (Fig. 1C). 

Phrase: "The iron chelator deferoxamine almost completely"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C2266987:Iron Chelator [Pharmacologic Substance]
   804   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0205197:Completely [Qualitative Concept]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1664784:Chelator [Eukaryote]

Phrase: "abolished"

Phrase: "cytoplasmic redox staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.163: In contrast, adding iron treatment to sections prior to measuring returned redox activity with no difference between AD and control samples (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "iron treatment to sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "prior to measuring returned redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1151028:redox activity [Molecular Function]
   861   C2266998:Redox Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "with no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "between AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: These observations suggest the possibility that the redox activity localized in the cytoplasm is because of iron associated with RNA in neurons. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "localized in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0392752:Localized [Spatial Concept]

Phrase: "is because of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]

Phrase: "associated with RNA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.165: To examine whether the redox activity in CA1 pyramidal neurons is derived from redox-active iron (Fe2+), we investigated hippocampus by iron(II) staining (13). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the redox activity in CA1 pyramidal neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1151028:redox activity [Molecular Function]
   778   C2266998:Redox Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "derived from redox-active iron"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030012:Redox [Molecular Function]
   760   C0205177:Active [Functional Concept]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "(Fe2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346592:Fe2+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "hippocampus by iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   790   C0949582:Hippocampus [Fish]
   790   C1029104:Hippocampus [Fish]
   790   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.166: In AD cases (n = 4) the neuronal cytoplasm of CA1 pyramidal neurons was stained clearly, whereas the staining was faint in age- and PMI-matched control (n = 5) (mean age (year)  S.D.: 

Phrase: "In AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "the neuronal cytoplasm of CA1 pyramidal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   748   C0010834:Cytoplasm [Cell Component]

Phrase: "was"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "clearly,"

Phrase: "whereas"

Phrase: "the staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "faint in age-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0039070:Faint [Sign or Symptom]

Phrase: "and"

Phrase: "PMI-matched control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0150103:matched [Research Activity]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1708943:Matched [Qualitative Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(mean age (year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.167: AD 76.7  11.3; 

Phrase: "AD 76.7  11.3"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   904   C1843013:Alzheimer disease 3 [Disease or Syndrome]
   885   C1853360:Alzheimer Disease 11 [Disease or Syndrome]
   867   C1853555:Alzheimer Disease 7 [Disease or Syndrome]
   848   C0067430:MAL-3 [Organic Chemical]
   848   C1425077:MALS-3 [Gene or Genome]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.168: control: 76.6  8.11; 

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "76.6  8.11"

Phrase: ";"
Processing 00000000.tx.169: mean PMI (hour)  S.D.: 

Phrase: "mean PMI (hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439227:Hour [Temporal Concept]
   827   C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.170: AD 17.5  14.6, control: 26.7  11.0) (Fig. 2, A and B). 

Phrase: "AD 17.5  14.6,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   904   C1854187:Alzheimer Disease 6 [Disease or Syndrome]
   885   C1970144:Alzheimer Disease 14 [Disease or Syndrome]
   867   C1412178:Alzheimer disease 5 [Gene or Genome]
   867   C1865868:ALZHEIMER DISEASE 5 [Disease or Syndrome]
   861   C3554452:ALZHEIMER DISEASE 17 [Disease or Syndrome]
   848   C0048433:MAL-6 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   811   C0067430:MAL-5 [Organic Chemical]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "26.7  11.0"

Phrase: ")"

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.171: This difference was also significant (p = 0.0001; Fig. 2C). 

Phrase: "This difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "also significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(p = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2C"

Phrase: ")."
Processing 00000000.tx.172: RNase pretreatment almost completely abolished cytoplasmic iron(II) staining (Fig. 2E), whereas DNase had little effect (Fig. 2F), indicating the physical association of redox-active iron with RNA in the neuronal cytoplasm. 

Phrase: "RNase pretreatment almost completely"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0205197:Completely [Qualitative Concept]
   812   C1550147:Pretreatment [Substance]
   812   C2709094:pre treatment [Temporal Concept]
   812   C3539075:Pretreatment [Temporal Concept]
   812   C3539076:Pretreatment [Activity]

Phrase: "abolished"

Phrase: "cytoplasmic iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 2E"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "DNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "had"

Phrase: "little effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 2F"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the physical association of redox-active iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the neuronal cytoplasm."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.173: View larger version (210K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(210K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.175: Ultramicroscopic localization shows redox activity is associated with the endoplasmic reticulum. 

Phrase: "Ultramicroscopic localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "associated with the endoplasmic reticulum."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.176: Following redox DAB staining, and subsequent gold labeling with DAB antiserum, localization of DAB was examined by electron microscopy. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "redox DAB staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "subsequent gold labeling with DAB antiserum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "localization of DAB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "examined by electron microscopy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C3463986:Electron [Bird]
Processing 00000000.tx.177: The redox activity (arrows) is mainly associated with the endoplasmic reticulum adjacent to the nucleus (N). 

Phrase: "The redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "is"

Phrase: "mainly"

Phrase: "associated with the endoplasmic reticulum"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "adjacent to the nucleus (N)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent
Processing 00000000.tx.178: Scale bar = 1 m.  

Phrase: "Scale bar = 1 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.179: To get further insights into the association of redox activity and RNA, we examined the localization of the redox activity ultrastructually. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "get"

Phrase: "further insights into the association of redox activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: "and"

Phrase: "RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the localization of the redox activity ultrastructually."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.180: Electron microscopic observation demonstrated the presence of redox activity in association with the endoplasmic reticulum, consistent with the involvement of RNA (Fig. 3). 

Phrase: "Electron microscopic observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0369671:Microscopic observation [Laboratory Procedure]
   827   C0302523:Observation [Research Activity]
   827   C0700325:observation [Health Care Activity]
   827   C1964257:Observation [Diagnostic Procedure]
   755 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "demonstrated"

Phrase: "the presence of redox activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with the endoplasmic reticulum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "consistent with the involvement of RNA (Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: ")."
Processing 00000000.tx.181: Ribosomal RNA Provides the Largest Site for Redox Iron Binding in NeuronsBecause our histological study suggested the association of redox-active iron to RNA, we examined whether there is any difference of iron binding among RNA species. 

Phrase: "Ribosomal RNA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1622954:ribosomal RNA [Cell Component]
   861   C0035553:Ribosomal [Cell Component]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "Provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the Largest Site for Redox Iron Binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0005456:Binding Site [Receptor]
   774   C0682969:Binding Site [Amino Acid Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "in NeuronsBecause"

Phrase: "our histological study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   950   C0681853:histologic study [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the association of redox-active iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "to RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "any difference of iron binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "among RNA species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.182: Purified bovine rRNA and tRNA, and mRNA from the M-17 human neuroblastoma cell line were compared for their ability to bind iron by dot blot analysis. 

Phrase: "Purified bovine rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "tRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "mRNA from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "M-"

Phrase: "17 human neuroblastoma cell line"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   888   C0682523:Human Cell Line [Cell]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell Line [Cell]
   840   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0205132:Line [Spatial Concept]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "were"

Phrase: "compared for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1707455:Compared [Activity]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "iron by dot blot analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
Processing 00000000.tx.183: Our preliminary experiment demonstrated that the amount of RNA or DNA blotted on the membrane is not saturated up to 10 g and revealed a positive linear relationship within this range (r2 = 0.9809 or r2 = 0.9977, respectively, data not shown). 

Phrase: "Our preliminary experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the amount of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "or"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "blotted on the membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "saturated up to 10 g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439267:g% [Quantitative Concept]
   760   C0522534:Saturated [Phenomenon or Process]
   760   C1705188:SATURATED [Quantitative Concept]

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a positive linear relationship within this range"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "(r2"

Phrase: "= 0.9809"

Phrase: "or"

Phrase: "r2"

Phrase: "= 0.9977,"

Phrase: "respectively,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.184: Therefore, we used 3.5 g of nucleic acids per dot in the following experiments for examining iron binding to nucleic acids. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3.5 g of nucleic acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "per dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "in the following experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "for examining iron binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1148613:iron binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "to nucleic acids."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acids [Chemical]
   861   C0007610:Nucleic [Cell Component]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.185: When equal amounts of RNA species were compared, rRNA showed significantly higher iron binding than tRNA (p < 0.0001) but similar iron binding to mRNA (Fig. 4A). 

Phrase: "When"

Phrase: "equal amounts of RNA species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: ","

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significantly higher iron binding than tRNA (p < 0.0001"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1148613:iron binding [Molecular Function]
   762   C1148901:tRNA binding [Genetic Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "but"

Phrase: "similar iron binding to mRNA (Fig. 4A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148613:iron binding [Molecular Function]
   774   C1148853:mRNA binding [Genetic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: ")."
Processing 00000000.tx.186: Then we considered the relative contribution of various RNA species to iron binding in a neuron. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the relative contribution of various RNA species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to iron binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1148613:iron binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "in a neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.187: If we considered the ratio of rRNA:tRNA:mRNA to be 71:15:3, the ratio found in cells (35), rRNA should have the largest iron binding capacity. 

Phrase: "If"

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the ratio of rRNA:tRNA:mRNA to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "be"

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "15"

Phrase: ":"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "found in cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0150312:Found [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0243095:Find [Finding]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "should"

Phrase: "have"

Phrase: "the largest iron binding capacity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0373658:Iron binding capacity [Laboratory Procedure]
   861   C0439155:Binding capacity [Quantitative Concept]
   861   C1148613:iron binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0376520:Iron [Inorganic Chemical]
   812   C1145667:Binding [Activity]
   812   C1166521:iron [Pharmacologic Substance]
   812   C1167622:Binding [Molecular Function]
   812   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.188: Indeed, when we performed a dot blot reflective of this ratio (rRNA:tRNA:mRNA = 3.5:0.74:0.15 g), rRNA showed the largest iron binding capacity (Fig. 4B). 

Phrase: "Indeed,"

Phrase: "when"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a dot blot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013064:dot blot [Laboratory Procedure]

Phrase: "reflective of this ratio"

Phrase: "(rRNA:tRNA:mRNA = 3.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1537998:trnA [Gene or Genome]

Phrase: ":"

Phrase: "0.74"

Phrase: ":"

Phrase: "0.15 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the largest iron binding capacity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0373658:Iron binding capacity [Laboratory Procedure]
   861   C0439155:Binding capacity [Quantitative Concept]
   861   C1148613:iron binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0376520:Iron [Inorganic Chemical]
   812   C1145667:Binding [Activity]
   812   C1166521:iron [Pharmacologic Substance]
   812   C1167622:Binding [Molecular Function]
   812   C1516240:Capacity [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: Although we observed a significant difference of iron binding capacity between tRNA and rRNA (p < 0.0001), following denaturation of RNA, the iron binding capacity decreased significantly (p = 0.0062) and the difference of iron binding capacity disappeared, suggesting the involvement of secondary or a higher structure in redox iron binding (Fig. 4C). 

Phrase: "Although"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant difference of iron binding capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between tRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "rRNA (p < 0.0001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "denaturation of RNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1720790:RNA Denaturation [Natural Phenomenon or Process]
   790   C0301642:Denaturation [Molecular Function]

Phrase: "the iron binding capacity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0373658:Iron binding capacity [Laboratory Procedure]
   901   C0439155:Binding capacity [Quantitative Concept]
   901   C1148613:iron binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1145667:Binding [Activity]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1167622:Binding [Molecular Function]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "significantly"

Phrase: "(p = 0.0062"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "the difference of iron binding capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "disappeared"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of secondary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "or"

Phrase: "a higher structure in redox iron binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.190: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 4. 

Phrase: "4."
Processing 00000000.tx.192: Redox iron binding to purified RNA. 

Phrase: "Redox iron binding to purified RNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1148613:iron binding [Molecular Function]
   783   C1148846:RNA Binding [Genetic Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
Processing 00000000.tx.193: A, following application of nucleic acids to dot blots, the membrane was incubated with a mixture of 0.1 mM ferrous chloride and 0.1 mM ferric citrate in MES buffer. 

Phrase: "A,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "application of nucleic acids to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "blots,"

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with a mixture of 0.1 mM ferrous chloride"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0060275:ferrous chloride [Inorganic Chemical,Pharmacologic Substance]
   757   C1418486:MM-1 [Gene or Genome]
   739   C0008203:Chloride, NOS [Inorganic Chemical]
   739   C0439962:Mixture [Substance]
   739   C0596019:Chloride [Element, Ion, or Isotope]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C2346592:Ferrous [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "0.1 mM ferric citrate in MES buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0060231:ferric citrate [Inorganic Chemical]
   767   C3256468:citrate buffer [Pharmacologic Substance]
   744   C0008857:Citrate [Organic Chemical]
   744   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   744   C2346593:Ferric [Element, Ion, or Isotope]
Processing 00000000.tx.194: In controls, nucleic acids were incubated with buffer alone. 

Phrase: "In controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "nucleic acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acids [Chemical]
   861   C0007610:Nucleic [Cell Component]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated with buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.195: After the redox staining, the mean density of each dot was compared. 

Phrase: "After the redox staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "the mean density of each dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.196: The experiment was performed in triplicate and data are presented as mean  S.E. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as mean"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0444504:Mean [Quantitative Concept]
   790   C0449450:Presented [Idea or Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.197: Note that rRNA shows about twice the redox-active iron binding capacity of tRNA (p = 0.0001, t test). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "shows about twice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1547282:Show [Intellectual Product]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "the redox-active iron binding capacity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0373658:Iron binding capacity [Laboratory Procedure]
   840   C0439155:Binding capacity [Quantitative Concept]
   840   C1148613:iron binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1145667:Binding [Activity]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1167622:Binding [Molecular Function]
   804   C1516240:Capacity [Quantitative Concept]

Phrase: "of tRNA (p = 0.0001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1537998:trnA [Gene or Genome]

Phrase: "t test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.198: B, different amounts of RNA reflecting the RNA ratio of neurons (detailed under "Results") was blotted on membrane and then incubated with an iron mixture or buffer alone. 

Phrase: "B,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "different amounts of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the RNA ratio of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "("

Phrase: "detailed under ""Results"""
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1522508:Detailed [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C1561567:detail [Functional Concept]
   756   C2825142:Result [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "blotted on membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025255:Membrane [Tissue]
   790   C0596901:Membrane [Cell Component]
   790   C1706182:Membrane [Manufactured Object]
   718 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with an iron mixture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C0439962:Mixture [Substance]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.199: C, effect of denaturation on redox iron binding was compared between tRNA and rRNA with or without denaturation by formamide and formaldehyde. 

Phrase: "C,"

Phrase: "effect of denaturation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on redox iron binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1148613:iron binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "compared between tRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1537998:trnA [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "rRNA with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or without denaturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301642:Denaturation [Molecular Function]

Phrase: "by formamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016568:formamide [Organic Chemical]

Phrase: "and"

Phrase: "formaldehyde."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.200: Note, denaturation significantly decreases iron binding of rRNA (p = 0.0062) and results in a level similar to that of tRNA.  

Phrase: "Note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "denaturation significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0301642:Denaturation [Molecular Function]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "iron binding of rRNA (p = 0.0062"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148613:iron binding [Molecular Function]
   774   C1148884:rRNA binding [Genetic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "results in a level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1547707:Level [Geographic Area]
   770   C2825142:Result [Finding]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "similar to that of tRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.201: Difference of Iron Bound to RNA Influences the Extent of RNA OxidationOur findings from brain tissue sections suggested the physical association of redox-active iron to cytoplasmic RNA. 

Phrase: "Difference of Iron"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1705241:*Difference [Quantitative Concept]
   790   C1705242:Difference [Qualitative Concept]
   718 E C0443199:Differential [Qualitative Concept]

Phrase: "Bound to RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "Influences"

Phrase: "the Extent of RNA OxidationOur findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "from brain tissue sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C0440746:Brain tissue [Tissue]
   734   C0459385:Brain tissue [Body Part, Organ, or Organ Component]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the physical association of redox-active iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "to cytoplasmic RNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827481:Cytoplasmic RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.202: Because free radicals mediate 8-OHG formation via the Fenton reaction (36), we hypothesized that iron bound to rRNA is responsible for RNA oxidation in neurons vulnerable to AD. 

Phrase: "Because"

Phrase: "free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "8-OHG formation via the Fenton reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0679088:reaction formation [Mental Process]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "bound to rRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "is"

Phrase: "responsible for RNA oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "vulnerable to AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0012655:vulnerability to disease [Clinical Attribute]
           disease vulnerability
Processing 00000000.tx.203: Inducing the Fenton reaction with 200 M ferrous chloride, 200 M ferric citrate, and 10 mM hydrogen peroxide resulted in cleavage of rRNA and formation of 8-OHG, as observed by Northwestern blotting (Fig. 5A). 

Phrase: "Inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "the Fenton reaction with 200 M ferrous chloride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]

Phrase: "200 M ferric citrate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0060231:ferric citrate [Inorganic Chemical]
   812   C0008857:Citrate [Organic Chemical]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C2346593:Ferric [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "10 mM hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0020275:Hydrogen [Element, Ion, or Isotope]
   812   C0031180:Peroxide [Inorganic Chemical]
   812   C0523702:HYDROGEN [Laboratory Procedure]
   812   C0885426:hydrogen [Inorganic Chemical]

Phrase: "resulted in cleavage of rRNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010813:cleavage [Cell Function]
   760   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "formation of 8-OHG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "observed by Northwestern blotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441672:Observed [Functional Concept]
   770   C1709274:Northwestern [Spatial Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.204: Treatment with iron or hydrogen peroxide alone induced neither rRNA cleavage nor 8-OHG formation, indicating that both hydrogen peroxide and iron are required for rRNA oxidation. 

Phrase: "Treatment with iron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "hydrogen peroxide alone induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205263:Induced [Functional Concept]

Phrase: "neither rRNA cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "nor"

Phrase: "8-OHG formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "both hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "are"

Phrase: "required for rRNA oxidation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030011:Oxidation [Molecular Function]
   770   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1514873:Required [Functional Concept]
Processing 00000000.tx.205: View larger version (42K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.207: rRNA is oxidized by the Fenton reaction. 

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "oxidized by the Fenton reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.208: A, rRNA was treated with iron and/or hydrogen peroxide (detailed under "Results") and then electrophoresed on a 1.2% agarose formamide/formaldehyde denaturing gel. 

Phrase: "A,"

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "treated with iron"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0376520:Iron [Inorganic Chemical]
   790   C1166521:iron [Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and/or"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "("

Phrase: "detailed under ""Results"""
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1522508:Detailed [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C1561567:detail [Functional Concept]
   756   C2825142:Result [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "electrophoresed on a 1.2% agarose formamide/formaldehyde denaturing gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C1706746:Agarose Gel [Research Device]
   739   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   739   C0016568:formamide [Organic Chemical]
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C0036681:Agarose [Carbohydrate]
   739   C1382104:Gel [Substance]
   706   C0013855:electrophorese [Laboratory Procedure]
Processing 00000000.tx.209: Note that rRNA was cleaved by the Fenton reaction (left). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cleaved by the Fenton reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.210: Northwestern blotting by anti-8-OHG antibody was performed on a membrane transferred from the presented gel (right). 

Phrase: "Northwestern blotting by anti-8-OHG antibody"

Phrase: "was"

Phrase: "performed on a membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C0884358:Performed [Functional Concept]
   770   C1706182:Membrane [Manufactured Object]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "transferred from the presented gel"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0348011:transferred [Functional Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1382104:Gel [Substance]
   726 E C0040671:Transfer [Mental Process]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1705822:Transfer [Activity]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.211: Note that 8-OHG was formed by the Fenton reaction. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that 8-OHG"

Phrase: "was"

Phrase: "formed by the Fenton reaction."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205431:Formed [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.212: B, difference of the amounts of 8-OHG formation between tRNA and rRNA. 

Phrase: "B,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "difference of the amounts of 8-OHG formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between tRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "rRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.213: Equal weight (200 g) of RNA was oxidized (ox) by the Fenton reaction. 

Phrase: "Equal weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]

Phrase: "(200 g) of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "oxidized (ox) by the Fenton reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.214: The formation of 8-OHG was examined by immunodot analysis using a monoclonal antibody (15A3) to 8-OHG. 

Phrase: "The formation of 8-OHG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "examined by immunodot analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "(15A3"

Phrase: ")"

Phrase: "to 8-OHG."
Processing 00000000.tx.215: The oxidation of rRNA produced 13 times more 8-OHG than tRNA (p < 0.0001, comparison between ox-tRNA and ox-rRNA), expressed as mean density  S.E. from experiments done in triplicate.  

Phrase: "The oxidation of rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "produced"

Phrase: "13 times more 8-OHG"

Phrase: "than tRNA (p < 0.0001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1537998:trnA [Gene or Genome]

Phrase: "comparison between ox-tRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "ox-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "expressed as mean density"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178587:density [Quantitative Concept]
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "done in triplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
Processing 00000000.tx.216: To determine whether the amount of iron bound to RNA influences the extent of oxidative damage to RNA, we examined the formation of 8-OHG between tRNA and rRNA, which demonstrated a significant difference in iron binding capacity (Fig. 4A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the amount of iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound to RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "influences"

Phrase: "the extent of oxidative damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "to RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the formation of 8-OHG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "between tRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "rRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "a significant difference in iron binding capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.217: Following the oxidation of 200 g of RNA by the Fenton reaction, rRNA generated 13 times more 8-OHG than tRNA (Fig. 5B). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the oxidation of 200 g of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "by the Fenton reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "13 times more 8-OHG than tRNA (Fig. 5B"

Phrase: ")."
Processing 00000000.tx.218: Demonstration of Redox-active Iron Associated with Ribosomes Isolated from Human BrainTo demonstrate the physical association of iron to ribosomes in brain, ribosomes were purified from hippocampus of AD (n = 6) and age- and postmortem interval-matched and control (n = 5) (mean age (year)  S.D.: 

Phrase: "Demonstration of Redox-active Iron"

Phrase: "Associated with Ribosomes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035553:Ribosomes [Cell Component]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C2984240:Ribosome [Functional Concept]

Phrase: "Isolated from Human BrainTo"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "the physical association of iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "to ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "were"

Phrase: "purified from hippocampus of AD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   753   C1998793:Purified [Functional Concept]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "postmortem interval-matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(mean age (year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.219: AD 77.83  10.57; 

Phrase: "AD 77.83  10.57"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   885   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.220: control: 74.20  8.92; 

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "74.20  8.92"

Phrase: ";"
Processing 00000000.tx.221: mean PMI (hour)  S.D.: 

Phrase: "mean PMI (hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439227:Hour [Temporal Concept]
   827   C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ":"
Processing 00000000.tx.222: AD 16.29  8.10, control: 15.4  7.09) by sucrose gradients. 

Phrase: "AD 16.29  8.10,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   904   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
   885   C1846735:ALZHEIMER DISEASE 8 [Disease or Syndrome]
   861   C2677888:Alzheimer Disease 16 [Disease or Syndrome]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "15.4  7.09"

Phrase: ")"

Phrase: "by sucrose gradients."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]
Processing 00000000.tx.223: The representative ribosome profiles are similar between AD and control (Fig. 6A). 

Phrase: "The representative ribosome profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "are"

Phrase: "similar between AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.224: Following collection of the monosome peak (arrow) and further purification by ultracentrifugation through a 1 M sucrose cushion, we examined whether there is a difference in the amount of iron bound to ribosomes. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "collection of the monosome peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "further purification by ultracentrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "through a 1 M sucrose cushion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0180249:cushion [Medical Device]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "a difference in the amount of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "bound to ribosomes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0035553:Ribosomes [Cell Component]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   756 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.225: We could not exclude the possibility that tissue iron would redistribute to ribosomes during the purification procedure and bias our data based on total iron content, which is reported greater in AD (37). 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that tissue iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "would"

Phrase: "redistribute to ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0035553:Ribosomes [Cell Component]
   756 E C2984240:Ribosome [Functional Concept]

Phrase: "during the purification procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "based on total iron content,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C0423896:Content [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "greater in AD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.226: To address this effect in our analysis, we normalized the data to the amount of iron in purified ribosomes by the total iron found in the same brain homogenate. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this effect in our analysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "the data to the amount of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "in purified ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035553:Ribosomes [Cell Component]
   827 E C2984240:Ribosome [Functional Concept]

Phrase: "by the total iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "found in the same brain homogenate."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0150312:Found [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.227: The iron(II) staining and redox staining on dot blotting showed that the density ratio of iron in ribosomes from AD is significantly higher than that of control (p = 0.00089, p = 0.032, respectively: Fig. 

Phrase: "The iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "redox staining on dot blotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the density ratio of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "in ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "from AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "significantly higher than that of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(p = 0.00089,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "p = 0.032,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ":"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.228: 6B). 

Phrase: "6B"

Phrase: ")."
Processing 00000000.tx.229: Although iron(III) staining revealed an increase of redox-inert Fe3+ in ribosomes from AD, it did not reach statistical significance (p = 0.051). 

Phrase: "Although"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an increase of redox-inert Fe3+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "from AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(p = 0.051"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.230: To determine whether the iron in ribosomes of AD is associated with ribosomal proteins or rRNA, we examined the purified ribosomes treated with either proteinase or RNase. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the iron in ribosomes of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C1166521:iron [Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with ribosomal proteins"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C1622856:ribosomal protein [Genetic Function]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0035553:Ribosomal [Cell Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "rRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the purified ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035553:Ribosomes [Cell Component]
   827 E C2984240:Ribosome [Functional Concept]

Phrase: "treated with either proteinase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1622131:proteinase [Molecular Function]
   770   C1947941:Proteinase [Enzyme]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "RNase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.231: Treatment with RNase A abolished iron(II) staining and significantly reduced redox staining, although treatment with proteinase K did not (p = 0.00014 and p = 0.021, respectively: Fig. 

Phrase: "Treatment with RNase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "A abolished iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "significantly reduced redox staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "although"

Phrase: "treatment with proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not (p = 0.00014"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "p = 0.021,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ":"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.232: 6C). 

Phrase: "6C"

Phrase: ")."
Processing 00000000.tx.233: To exclude the possibility of contamination with ferritin polymers, we examined the ribosomal pellet by immunoblotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of contamination"

Phrase: "with ferritin polymers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   755 E C1218520:Polymeria [Plant]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ribosomal pellet by immunoblotting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.234: Immunoblotting using an anti-human ferritin antibody did not reveal any bands in the ribosome pellet (data not shown). 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-human ferritin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any bands in the ribosome pellet"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.235: We also addressed whether ribosomes purified from AD brain shows oxidative modification of rRNA. 

Phrase: "We also"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "purified from AD brain"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0006111:Brain Disease [Disease or Syndrome]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0012634:Disease [Disease or Syndrome]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1998793:Purified [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "oxidative modification of rRNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158756:rRNA modification [Genetic Function]
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.236: Although cleavage of the rRNA and presence of 8-OHG was examined by gel electrophoresis and dot blot analysis of ribosome samples, we could detect neither (data not shown). 

Phrase: "Although"

Phrase: "cleavage of the rRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "presence of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "examined by gel electrophoresis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0596607:Gel Electrophoresis [Laboratory Procedure]
   819 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   770   C0013855:Electrophoresis [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0332128:Examined [Finding]
   770   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "dot blot analysis of ribosome samples,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1303103:Sample analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "neither"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.237: Because there is a possibility that the amount of 8-OHG did not reach the detectable level for dot blot analysis, we performed RT-PCR with primers specific for human 28 S and 18 S rRNA fragments following immunoprecipitation with anti-8-OHG monoclonal antibody (31). 

Phrase: "Because"

Phrase: "there"

Phrase: "is"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the amount of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the detectable level for dot blot analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "RT-PCR with primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "specific for human 28 S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "18 S rRNA fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunoprecipitation with anti-8-OHG monoclonal antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.238: Only the ribosomes from AD showed 8-OHG (Fig. 7). 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the ribosomes from AD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035553:Ribosomes [Cell Component]
   726 E C2984240:Ribosome [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "8-OHG"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.239: PCR samples without reverse transcription, immunoprecipitation with omission of the primary antibody, or preincubation with 8-OHG did not show any amplification, confirming the specificity of the procedures. 

Phrase: "PCR samples without reverse transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "immunoprecipitation with omission of the primary antibody,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "or"

Phrase: "preincubation with 8-OHG"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of the procedures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.240: Effect of Oxidized Ribosomes on in Vitro translationTo address the pathophysiological effect of iron-mediated oxidative stress to ribosomes, we oxidized ribosomes purified from rabbit reticulocyte and examined their effect on protein synthesis directed by poly(U) in vitro. 

Phrase: "Effect of Oxidized Ribosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on in Vitro translationTo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the pathophysiological effect of iron-mediated oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "to ribosomes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "we"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "purified from rabbit reticulocyte"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034493:Rabbit [Mammal]
   770   C0035286:Reticulocyte [Cell]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "their effect on protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "directed by poly(U"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0747726:POLY [Conceptual Entity]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: ")"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.241: The Fenton reaction successfully oxidized ribosomes, which was demonstrated by cleavage of rRNA (Fig. 8A). 

Phrase: "The Fenton reaction successfully oxidized ribosomes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0035553:Ribosomes [Cell Component]
   771 E C2984240:Ribosome [Functional Concept]

Phrase: "which"

Phrase: "was"

Phrase: "demonstrated by cleavage of rRNA (Fig. 8A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0010813:cleavage [Cell Function]
   748   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0349966:Fig [Food]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
   748   C1337208:FIG [Food]
   748   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.242: After treatment, each ribosome sample was incubated with reaction mixture containing poly(U) mRNA, [14C]Phe-tRNA, and elongation factors (see "Materials and Methods"). 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "each ribosome sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "incubated with reaction mixture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439962:Mixture [Substance]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[14C"

Phrase: "]Phe-tRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "elongation factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0086206:Elongation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.243: Ribosomes oxidized by the Fenton reaction showed a significant reduction of protein synthesis (p = 0.0012; compared with control, Fig. 8B). 

Phrase: "Ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "oxidized by the Fenton reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726   C0030011:oxidize [Molecular Function]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant reduction of protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(p = 0.0012"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "compared with control,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.244: Although treatment with hydrogen peroxide showed a slight decrease of protein synthesis, it was not statistically significant (p = 0.10; compared with control).  

Phrase: "Although"

Phrase: "treatment with hydrogen peroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a slight decrease of protein synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(p = 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.245: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In this study we demonstrated the possibility that redox-active iron plays a pivotal role in RNA oxidation in the vulnerable neurons of AD based on the following findings: 1) we showed a significant increase of redox activity and iron(II) in CA1 pyramidal neurons in AD compared with age-matched controls that are susceptible to RNase, suggesting the physical association of redox-active iron(II) to RNA in the neuronal cytoplasm. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "the possibility"

Phrase: "that redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role in RNA oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the vulnerable neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "based on the following findings"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0243095:Finding [Finding]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C2825141:Finding [Finding]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant increase of redox activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "in CA1 pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "susceptible to RNase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231204:Susceptible [Functional Concept]
   790   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the physical association of redox-active iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(II"

Phrase: ")"

Phrase: "to RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the neuronal cytoplasm."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.246: 2) Demonstration of redox activity associated with the endoplasmic reticulum at the ultrastructural level. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Demonstration of redox activity"

Phrase: "associated with the endoplasmic reticulum"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "at the ultrastructural level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.247: 3) Dot blot analysis showed that among the major RNA species in a neuron, rRNA has the greatest redox iron binding capacity. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that among the major RNA species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205164:Major [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]

Phrase: "in a neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "the greatest redox iron binding capacity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0373658:Iron binding capacity [Laboratory Procedure]
   840   C0439155:Binding capacity [Quantitative Concept]
   840   C1148613:iron binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1145667:Binding [Activity]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1167622:Binding [Molecular Function]
   804   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.248: 4) Reflecting the difference of bound iron, the greatest amount of 8-OHG was found in rRNA. 

Phrase: "4"

Phrase: ")"

Phrase: "Reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the difference of bound iron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "the greatest amount of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "found in rRNA."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.249: 5) Ribosomes purified from hippocampus of cases of AD were oxidized and showed a significantly higher amount of redox-active iron(II) than control and the iron(II) bound to ribosome were also susceptible to RNase. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "Ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "purified from hippocampus of cases of AD"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   744   C0868928:Cases [Functional Concept]
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   744   C1533148:Cases [Quantitative Concept]
   744   C1998793:Purified [Functional Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significantly higher amount of redox-active iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "than control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "bound to ribosome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0035553:Ribosome [Cell Component]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   790   C2984240:Ribosome [Functional Concept]

Phrase: "were"

Phrase: "also susceptible to RNase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.250: Furthermore, we addressed the biological effect of oxidization of ribosomes mediated by redox-active iron on protein synthesis and found that it causes significant reduction of protein synthesis. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the biological effect of oxidization of ribosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "mediated by redox-active iron"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030012:Redox [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205177:Active [Functional Concept]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]

Phrase: "on protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "significant reduction of protein synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.251: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.252: 6. 

Phrase: "6."
Processing 00000000.tx.253: Ribosomes from AD demonstrate redox-active iron. 

Phrase: "Ribosomes from AD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035553:Ribosomes [Cell Component]
   737 E C2984240:Ribosome [Functional Concept]

Phrase: "demonstrate"

Phrase: "redox-active iron."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
Processing 00000000.tx.254: A, representative ribosome profile purified from AD and control hippocampus. 

Phrase: "A,"

Phrase: "representative ribosome profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "purified from AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1998793:Purified [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.255: Following ultracentrifugation of the postmitochondrial fraction on 1540% sucrose gradients, the ribosome profile was determined using a UV spectrometer. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ultracentrifugation of the postmitochondrial fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041609:Ultracentrifugation [Laboratory Procedure]

Phrase: "on 1540% sucrose gradients,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]

Phrase: "the ribosome profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a UV spectrometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183395:Spectrometer [Medical Device]
   861   C1710143:Spectrometer [Manufactured Object]
Processing 00000000.tx.256: AD and control hippocampus showed similar ribosome profiles. 

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar ribosome profiles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]
Processing 00000000.tx.257: Arrows indicate monosome peaks. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "monosome peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]
Processing 00000000.tx.258: B, purified ribosomes from AD and control hippocampus were blotted on membranes and examined for their content of iron(II), iron(III), and redox activity as described under "Materials and Methods." 

Phrase: "B,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "purified ribosomes from AD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035553:Ribosomes [Cell Component]
   726 E C2984240:Ribosome [Functional Concept]

Phrase: "and"

Phrase: "control hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "blotted on membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "examined for their content of iron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0332128:Examined [Finding]
   753   C0376520:Iron [Inorganic Chemical]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]
   753   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: ","

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.259: Iron(II) and redox activity in AD were significantly higher than that in control (p = 0.00089 and p = 0.032, respectively). 

Phrase: "Iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "redox activity in AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1151028:redox activity [Molecular Function]
   806   C2266998:Redox Activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "significantly higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(p = 0.00089"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "p = 0.032,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.260: C, effect of RNase on iron(II) and redox activity in ribosome from AD. 

Phrase: "C,"

Phrase: "effect of RNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "redox activity in ribosome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1151028:redox activity [Molecular Function]
   833   C2266998:Redox Activity [Molecular Function]
   783   C1752485:active ribosome [Cell Component]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "from AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.261: Dot blots of ribosomes from AD were treated with RNase A or proteinase K, followed by subsequent iron(II) and redox staining. 

Phrase: "Dot blots of ribosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   816   C0013064:dot blot [Laboratory Procedure]

Phrase: "from AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "treated with RNase A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "proteinase K,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1708601:K' [Quantitative Concept]
   861   C1947941:Proteinase [Enzyme]

Phrase: "followed by subsequent iron"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0332282:Subsequent [Temporal Concept]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "redox staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.262: Note that both iron(II) and redox staining are susceptible to RNase but resistant to proteinase.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "both iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "redox staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "are"

Phrase: "susceptible to RNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231204:Susceptible [Functional Concept]
   790   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "but"

Phrase: "resistant to proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.263: Redox-active Iron in Neuronal Cytoplasm of Pyramidal NeuronsIn the present study, we used methacarn-fixed tissues, which augments the iron detection sensitivity in human tissue. 

Phrase: "Redox-active Iron in Neuronal Cytoplasm of Pyramidal NeuronsIn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0376520:Iron [Inorganic Chemical]
   742   C1166521:iron [Pharmacologic Substance]

Phrase: "the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methacarn-fixed tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "which"

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the iron detection sensitivity in human tissue."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0234235:Tissue sensitivity [Sign or Symptom]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.264: We previously found that even a brief postfixation with formaldehyde (3.7%, 560 min at room temperature) reduced iron labeling in a time-dependent manner (13). 

Phrase: "We previously"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that even"

Phrase: "a brief postfixation with formaldehyde"

Phrase: "(3.7%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "560 min at room temperature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "reduced iron labeling in a time-dependent manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.265: We also confirmed that iron localization in methacarn-fixed tissue is similar to that found in sections made from frozen blocks, which were neither fixed nor embedded, suggesting that iron localization is not a result of tissue fixation or embedding (13). 

Phrase: "We also"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that iron localization in methacarn-fixed tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in sections"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0150312:Found [Quantitative Concept]
   756   C0205155:Section [Spatial Concept]
   756 E C0243095:Find [Finding]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "made from frozen blocks,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028778:blocks [Pathologic Function]
   770   C0332206:Blocks [Functional Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1533157:Blocks [Substance]
   737 E C1706084:Block [Geographic Area]
   737   C1881534:Make [Functional Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "neither"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "nor"

Phrase: "embedded,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707903:Embedded [Laboratory Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that iron localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a result of tissue fixation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "or"

Phrase: "embedding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707903:Embedding [Laboratory Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.266: In AD, heme oxygenase-1 immunoreactivity is significantly increased in the cytoplasm of pyramidal neurons in the hippocampus (38). 

Phrase: "In AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "heme oxygenase-1 immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0597879:immunoreactivity [Molecular Function]
   756   C0538674:Heme Oxygenase-1 [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415619:HEME OXYGENASE 1 [Gene or Genome]
   708   C0759009:heme 1 [Organic Chemical]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased in the cytoplasm of pyramidal neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   748   C0010834:Cytoplasm [Cell Component]
   748   C0027882:Neurons [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.267: Although the source of iron is unknown, it is of note that the pattern of redox-active iron in pyramidal neurons is strikingly similar to the localization of heme oxygenase-1 and that it is the amount of redox-active iron that is critical to the differences in redox activity between cases of AD and control. 

Phrase: "Although"

Phrase: "the source of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "it"

Phrase: "is of"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the pattern of redox-active iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "in pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "strikingly similar to the localization of heme oxygenase-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "the amount of redox-active iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "critical to the differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "in redox activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151028:redox activity [Molecular Function]
  1000   C2266998:Redox Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.268: Because iron(II) is a product of the heme oxygenase reaction, our observation of the localization of iron(II) in the cytoplasm of the CA1 pyramidal neurons in hippocampus is intriguing. 

Phrase: "Because"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "is"

Phrase: "a product of the heme oxygenase reaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0368768:Blood product reaction [Pathologic Function]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
   724   C0456388:Blood product [Pharmacologic Substance]
   724   C1547007:Blood product [Idea or Concept]

Phrase: "our observation of the localization of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302523:Observation [Research Activity]
   748   C0700325:observation [Health Care Activity]
   748   C1964257:Observation [Diagnostic Procedure]

Phrase: "(II"

Phrase: ")"

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of the CA1 pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "intriguing."
Processing 00000000.tx.269: This fact may suggest that heme oxygenase-1 is involved in the production and accumulation of iron(II) in the cytoplasm of CA1 pyramidal neurons. 

Phrase: "This fact"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that heme oxygenase-1"
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
  1000   C0538674:Heme Oxygenase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415619:HEME OXYGENASE 1 [Gene or Genome]
   913   C0759009:heme 1 [Organic Chemical]
   901   C0018969:Haem Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0018966:Haem [Biologically Active Substance,Organic Chemical]
   827   C0030065:Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1622683:oxygenase [Molecular Function]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   727 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   727 E C1511228:VESSEL, BLOOD [Tissue]
   716 E C1558950:VASCULAR [Finding]
   716 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "involved in the production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033268:production [Occupational Activity]
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "accumulation of iron"

Phrase: "(II"

Phrase: ")"

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of CA1 pyramidal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.270: Hippocampus in cases of AD was reported to accumulate iron (39). 

Phrase: "Hippocampus in cases of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.271: Because the abnormality of mitochondria turnover was suggested in the AD brain, there is a possibility that accumulated iron is derived from turnover of the heme-containing enzymes of mitochondria (27). 

Phrase: "Because"

Phrase: "the abnormality of mitochondria turnover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C3278399:Abnormal mitochondria [Finding]
   760   C1704258:Abnormality [Finding]

Phrase: "was"

Phrase: "suggested in the AD brain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0006111:Brain Disease [Disease or Syndrome]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0012634:Disease [Disease or Syndrome]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719   C1705535:Suggest [Idea or Concept]

Phrase: "there"

Phrase: "is"

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that accumulated iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "is"

Phrase: "derived from turnover of the heme-containing enzymes of mitochondria"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0014442:Enzymes [Enzyme,Organic Chemical]
   739   C0014445:enzymes [Functional Concept]
   739   C0018966:Haem [Biologically Active Substance,Organic Chemical]
   739   C0026237:Mitochondria [Cell Component]
   739   C0031227:turnover [Quantitative Concept]
   739   C0243127:turnover [Functional Concept]
   739   C0332256:Containing [Functional Concept]
   739   C0443331:Turnover [Health Care Activity]
   739   C1441547:Derived [Qualitative Concept]
   739   C2700400:Containing [Activity]
   739   C3245521:derived [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.272: Iron Binding to RNABecause most catalytic RNAs depend on divalent metal ions such as Mg2+ for folding and catalysis, direct binding of divalent metal ions to RNA is used to probe the structure of RNA and their high affinity metal binding site (24, 40). 

Phrase: "Iron Binding to RNABecause most catalytic RNAs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148613:iron binding [Molecular Function]
   757   C1148846:RNA Binding [Genetic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "depend on divalent metal ions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0596455:divalent metal [Element, Ion, or Isotope]
   760   C0022023:Ions [Element, Ion, or Isotope]
   760   C0025552:Metal [Inorganic Chemical]
   760   C0725813:depend [Medical Device]
   726 E C1700702:ION [Functional Concept]

Phrase: "such as Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "for folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "catalysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:Catalysis [Natural Phenomenon or Process]

Phrase: "direct binding of divalent metal ions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   809   C1323274:Metal Ion Binding [Molecular Function]
           metal binding
   767   C1752728:ion binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the structure of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "their high affinity metal binding site"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C1513163:Metal Binding Site [Amino Acid Sequence]
   840   C0005456:Binding Site [Receptor]
   840   C0682969:Binding Site [Amino Acid Sequence]
   840   C1323274:metal binding [Molecular Function]
   804   C0025552:Metal [Inorganic Chemical]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   733 E C2986473:Metallic [Qualitative Concept]

Phrase: "(24,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.273: Berens et al. 

Phrase: "Berens et al."
Processing 00000000.tx.274: (24) investigated the metal ion-binding site of the group I intron. 

Phrase: "(24"

Phrase: ")"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the metal ion-binding site of the group I intron."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C1323274:Metal Ion Binding [Molecular Function]
           metal binding
   777   C1513163:Metal Binding Site [Amino Acid Sequence]
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   760   C1752728:ion binding [Molecular Function]
   760   C2945843:Site of [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.275: Fe2+-induced Fenton chemistry was used to take advantage of the ability of Fe2+ to functionally and structurally replace Mg2+ at ion-binding sites. 

Phrase: "Fe2+-induced Fenton chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007996:Chemistry [Occupation or Discipline]
   812   C0079107:chemistry [Classification]
   812   C0201682:Chemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "advantage of the ability of Fe2+"

Phrase: "to functionally"

Phrase: "and"

Phrase: "structurally"

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at ion-binding sites."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0005456:Binding Sites [Receptor]
   901   C1752728:ion binding [Molecular Function]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.276: At the site, iron can generate short-lived and highly reactive hydroxyl radicals that can cleave nucleic acid and protein backbones in spatial proximity of these ion-binding sites (24). 

Phrase: "At the site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "can"

Phrase: "generate"

Phrase: "short-lived"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2982691:Live [Activity]

Phrase: "and"

Phrase: "highly reactive hydroxyl radicals"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   812   C0302912:radicals [Chemical Viewed Structurally]
   812   C0700307:Hydroxyl [Inorganic Chemical]
   779 E C0439807:Radical [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "cleave"

Phrase: "nucleic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acid [Chemical]
   861   C0007610:Nucleic [Cell Component]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "protein backbones in spatial proximity of these ion-binding sites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0037949:backbones [Body Part, Organ, or Organ Component]
   706 E C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.277: They showed that Fe2+-induced Fenton reaction yields distinctly cleaved regions that occur only in the correctly folded RNA in the presence of Mg2+ and can be competed by additional Mg2+, suggesting that Fe2+ and Mg2+ interact with the same sites. 

Phrase: "They"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Fe2+-induced Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "yields"

Phrase: "distinctly cleaved regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "only in the correctly folded RNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205171:Only [Quantitative Concept]
   753   C0332462:Folded [Spatial Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1880834:FOLDED [Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "competed by additional Mg2+,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1417500:MG2 [Gene or Genome]
   770   C1524062:Additional [Functional Concept]
   770   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Fe2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346592:Fe2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "interact with the same sites."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205145:Sites [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.278: Of course we could not exclude the possibility of another type of metal ion binding mode to RNA (41). 

Phrase: "Of course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of another type of metal ion binding mode"

Phrase: "to RNA (41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.279: It is known that specific metal binding motifs in RNA tertiary structures exist. 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that specific metal binding motifs in RNA tertiary structures"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1323274:metal binding [Molecular Function]
   762   C1148846:RNA Binding [Genetic Function]
   762   C3178797:RNA Motifs [Nucleotide Sequence]
   742   C0025552:Metal [Inorganic Chemical]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   708   C1514562:Motif [Amino Acid Sequence]

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.280: Of note is the major groove of tandem G-U pairs. 

Phrase: "Of note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "the major groove of tandem G-U pairs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1518157:Major Groove [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205164:Major [Qualitative Concept]
   744   C1184482:Groove [Body Space or Junction]
Processing 00000000.tx.281: The major groove edge of guanosine (through the O6 and N7 atoms) is a particularly common ligand of magnesium-bound water (42). 

Phrase: "The major groove edge of guanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205154:Edge [Spatial Concept]
   753   C2697523:Edge [Conceptual Entity]

Phrase: "("

Phrase: "through the O6"

Phrase: "and"

Phrase: "N7 atoms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567415:Atoms [Element, Ion, or Isotope]
   827 E C1706222:Atom [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "a particularly common ligand of magnesium-bound water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0023688:Ligand [Chemical]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.282: This motif creates a cavity that possesses an unusually negative potential and provides a good ligand for metal ions and coordinated water molecules (43). 

Phrase: "This motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a cavity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011334:cavity [Disease or Syndrome]
  1000   C0333343:Cavity [Body Space or Junction]
  1000   C1510420:Cavity [Anatomical Abnormality]

Phrase: "that"

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "an unusually negative potential"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a good ligand for metal ions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023688:Ligand [Chemical]

Phrase: "and"

Phrase: "coordinated water molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.283: Because this motif provides a metal binding site where metal ions are accessible on the outer sphere of RNA molecules, it may be important for binding of redox-active iron. 

Phrase: "Because"

Phrase: "this motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a metal binding site where metal ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0022023:Ions [Element, Ion, or Isotope]
   766 E C1700702:ION [Functional Concept]

Phrase: "are"

Phrase: "accessible on the outer sphere of RNA molecules,"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "important for binding of redox-active iron."
Processing 00000000.tx.284: Biological Effect of Ribosome Oxidization by Redox-active IronReduction of protein synthesis has been suggested in AD (44, 45). 

Phrase: "Biological Effect of Ribosome Oxidization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "by Redox-active IronReduction"

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "suggested in AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737   C1705535:Suggest [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.285: Langstrom et al. 

Phrase: "Langstrom et al."
Processing 00000000.tx.286: (46) reported that polysomes purified from the AD frontal cortices showed 50% reduction of the translational activity per unit polysome than that of control. 

Phrase: "(46"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that polysomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032592:Polysomes [Cell Component]
  1000   C2324468:Polysomes [Cell Component]

Phrase: "purified from the AD frontal cortices"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205123:Frontal [Spatial Concept]
   748   C1998793:Purified [Functional Concept]
   745   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   714   C0007776:Cortex [Body Part, Organ, or Organ Component]
   714   C1176472:Cortex [Body Part, Organ, or Organ Component]
   714   C2700441:Cortex [Plant]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "50% reduction of the translational activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "per unit polysome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032592:polysome [Cell Component]

Phrase: "than that"

Phrase: "of control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.287: Although increased phosphorylation of eEF-2 in AD brain (that results in inhibition of translation) was reported (47), the mechanism of reduced protein synthesis in AD brain is still unclear. 

Phrase: "Although"

Phrase: "increased phosphorylation of eEF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in AD brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "("

Phrase: "that results in inhibition of translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "the mechanism of reduced protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in AD brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "is"

Phrase: "still unclear."
Processing 00000000.tx.288: Because we added active eEFs (eEF-1 and eEF-2) separately in the poly(U) assay system, we negated the effect of inactivation of eEF-2 by oxidization mediated via redox-active iron. 

Phrase: "Because"

Phrase: "we"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "active eEFs"

Phrase: "(eEF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414290:EEF-1 [Gene or Genome]

Phrase: "and"

Phrase: "eEF-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414295:EEF-2 [Gene or Genome]

Phrase: ")"

Phrase: "separately in the poly(U"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "we"

Phrase: "negated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Negated [Functional Concept]

Phrase: "the effect of inactivation of eEF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "by oxidization"

Phrase: "mediated via redox-active iron."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030012:Redox [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205177:Active [Functional Concept]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
Processing 00000000.tx.289: Our results suggested that oxidization of ribosome by redox-active iron could be the direct cause of protein synthesis reduction in AD, whereas the question of what type of oxidative modifications (cleavage of sugar backbone, base modification, depurination, cross-linking etc.) are the most responsible for this inhibitory effect remains to be answered. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that oxidization of ribosome"

Phrase: "by redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "the direct cause of protein synthesis reduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "in AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "whereas"

Phrase: "the question of what type of oxidative modifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522634:Question [Intellectual Product]

Phrase: "(cleavage of sugar backbone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "base modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "depurination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1158480:Depurination [Genetic Function]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "etc.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "are"

Phrase: "the most responsible for this inhibitory effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "answered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]
Processing 00000000.tx.290: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.291: 7. 

Phrase: "7."
Processing 00000000.tx.292: Oxidized RNA is increased in ribosomes from AD. 

Phrase: "Oxidized RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "increased in ribosomes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0035553:Ribosomes [Cell Component]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756 E C2984240:Ribosome [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.293: Ribosomal RNA extracted from purified ribosome samples was immunoprecipitated with anti-8-OHG monoclonal antibody and followed by RT-PCR with specific primers for the human 28 S fragment (338 nt) and 18 S rRNA fragments (268 nt). 

Phrase: "Ribosomal RNA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1622954:ribosomal RNA [Cell Component]
   861   C0035553:Ribosomal [Cell Component]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "extracted from purified ribosome samples"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0035553:Ribosome [Cell Component]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1998793:Purified [Functional Concept]
   760   C2984240:Ribosome [Functional Concept]
   760   C3541890:EXTRACTED [Finding]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
   726 E C2828366:Extract [Substance]

Phrase: "was"

Phrase: "immunoprecipitated with anti-8-OHG monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "followed by RT-PCR"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for the human 28 S fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(338 nt)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "and"

Phrase: "18 S rRNA fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "(268 nt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.294: RT-PCR were performed individually with each of six AD samples and five controls for detection of the 28 S fragment. 

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "individually with each of six AD samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205452:Six [Quantitative Concept]
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "five controls for detection of the 28 S fragment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0243148:control [Qualitative Concept]
   708   C1550141:Control [Substance]
   708   C1882979:Control [Conceptual Entity]
   708   C2587213:Control [Functional Concept]
   708   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.295: Five AD and five control were examined to detect the 18 S rRNA fragment. 

Phrase: "Five AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "five control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the 18 S rRNA fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.296: As shown, only AD samples showed the existence of 8-OHG in rRNA. 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "only AD samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the existence of 8-OHG"

Phrase: "in rRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.297: M, markers. 

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.298: The negative controls are as follows: RT-PCR for the 28 S fragment with omission of anti-8-OHG primary antibody or that for the 18 S fragment, RT-PCR for the 28 S fragment following incubation with 8-OHG, or that for the 18 S fragment.  

Phrase: "The negative controls"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "RT-PCR for the 28 S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "fragment with omission of anti-8-OHG primary antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205225:Primary [Qualitative Concept]
   742   C0332255:fragment [Functional Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "that for the 18 S fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "RT-PCR for the 28 S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with 8-OHG,"

Phrase: "or"

Phrase: "that for the 18 S fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.299: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.300: 8. 

Phrase: "8."
Processing 00000000.tx.301: Oxidation of ribosomes reduces poly(U) in vitro translation. 

Phrase: "Oxidation of ribosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "reduces"

Phrase: "poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "in vitro translation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.302: A, oxidation of ribosomes by the Fenton reaction. 

Phrase: "A,"

Phrase: "oxidation of ribosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "by the Fenton reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.303: Ribosomes purified from rabbit reticulocytes were treated with/without iron and/or H2O2. 

Phrase: "Ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "purified from rabbit reticulocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034493:Rabbit [Mammal]
   770   C0035286:Reticulocytes [Cell]
   770   C1998793:Purified [Functional Concept]

Phrase: "were"

Phrase: "treated with/"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "without iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.304: Only the combination of the iron solution and H2O2 cleaved ribosomal RNA effectively. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the combination of the iron solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "ribosomal RNA effectively."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1622954:ribosomal RNA [Cell Component]
   827   C0035553:Ribosomal [Cell Component]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   755 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.305: B, poly(U) in vitro translation assay of oxidized ribosomes. 

Phrase: "B,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "in vitro translation assay of oxidized ribosomes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1515653:In Vitro Assay [Research Activity]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.306: The effect of oxidization of ribosomes on the efficacy of protein synthesis was investigated. 

Phrase: "The effect of oxidization of ribosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the efficacy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280519:Efficacy [Qualitative Concept]
  1000   C1707887:EFFICACY [Research Activity]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.307: Following treatment, each sample was transferred to reaction mixtures containing all the components necessary for the poly(U) assay and then in vitro translation was performed. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "transferred to reaction mixtures"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   802   C0678610:transfer reaction [Natural Phenomenon or Process]
   770   C0348011:transferred [Functional Concept]
   770   C0439962:mixtures [Substance]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "all the components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "necessary for the poly(U"

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "then in vitro translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040712:Translation [Intellectual Product]
   812   C0597295:translation [Molecular Function]
   812   C1519614:Translation [Genetic Function]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.308: After precipitation of protein from each reaction mixture, radioactivity was counted. 

Phrase: "After precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from each reaction mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.309: This experiment was performed in triplicate. 

Phrase: "This experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.310: Oxidization by the Fenton reaction resulted in significant reduction of protein synthesis (p = 0.0012, compared with control). 

Phrase: "Oxidization by the Fenton reaction"

Phrase: "resulted in significant reduction of protein synthesis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C0237881:significant [Quantitative Concept]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(p = 0.0012,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.311: No ribosomes denotes that poly(U) assay was performed without ribosomes. 

Phrase: "No ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "denotes"

Phrase: "that poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed without ribosomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0035553:Ribosomes [Cell Component]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   756 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.312: Untreated means the poly(U) assay was done by using untreated (with no sham operation) ribosomes.  

Phrase: "Untreated means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "the poly(U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032417:Poly U [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "done by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1272695:Done [Qualitative Concept]
   833   C2746065:Done [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "("

Phrase: "with no sham operation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0068899:S-HAM [Therapeutic or Preventive Procedure]
   861   C0073980:SHAM [Organic Chemical,Pharmacologic Substance]
   861   C0543467:Operation [Health Care Activity]
   861   C3241922:Operation [Activity]

Phrase: ")"

Phrase: "ribosomes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.313: Ribosomes consist of rRNA and ribosomal proteins. 

Phrase: "Ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "consist of rRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "ribosomal proteins."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1622856:ribosomal protein [Genetic Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0035553:Ribosomal [Cell Component]
   789 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.314: Therefore, ribosomal proteins would also be oxidized by the Fenton reaction. 

Phrase: "Therefore,"

Phrase: "ribosomal proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1622856:ribosomal protein [Genetic Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0035553:Ribosomal [Cell Component]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "would"

Phrase: "also"

Phrase: "be"

Phrase: "oxidized by the Fenton reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   726   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.315: Although it has been demonstrated that protein synthesis is catalyzed by the RNA of the ribosome and ribosomal proteins are abundant everywhere on its surface except in the active site where peptide bond formation occurs and where it associates with the small subunit (48), we could not conclude whether oxidative modification of RNA of the ribosome or ribosomal proteins is responsible for the decrease of protein synthesis. 

Phrase: "Although"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "catalyzed by the RNA of the ribosome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0035553:Ribosome [Cell Component]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2984240:Ribosome [Functional Concept]
   738   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1622954:ribosomal RNA [Cell Component]

Phrase: "and"

Phrase: "ribosomal proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1622856:ribosomal protein [Genetic Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0035553:Ribosomal [Cell Component]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "are"

Phrase: "abundant everywhere on its surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205148:Surface [Spatial Concept]
   760   C2346714:Abundant [Qualitative Concept]

Phrase: "except"

Phrase: "in the active site where peptide bond formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0678616:peptide bond formation [Natural Phenomenon or Process]
   839   C1327133:peptide formation [Molecular Function]
   799   C0220781:formation [Biologic Function]
   799   C0439634:formation [Spatial Concept]
   799   C1522492:Formation [Functional Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "where"

Phrase: "it"

Phrase: "associates with the small subunit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0700321:Small [Quantitative Concept]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C1711351:Subunit [Quantitative Concept]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "whether"

Phrase: "oxidative modification of RNA of the ribosome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158744:RNA modification [Genetic Function]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "or"

Phrase: "ribosomal proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1622856:ribosomal protein [Genetic Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0035553:Ribosomal [Cell Component]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "is"

Phrase: "responsible for the decrease of protein synthesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.316: Although the exact mechanism that makes a difference of 8-OHG formation among different RNA species through the Fenton reaction is still unclear, it has been shown that the production of 8-hydroxydeoxyguanosine is significantly increased when iron(II) is allowed to associate with deoxyguanosine prior to administration of H2O2 (36). 

Phrase: "Although"

Phrase: "the exact mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a difference of 8-OHG formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "among different RNA species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "through the Fenton reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "is"

Phrase: "still unclear,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the production of 8-hydroxydeoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(II"

Phrase: ")"

Phrase: "is"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with deoxyguanosine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "prior to administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.317: This finding is consistent with our results that the difference of iron bound to RNA may result in the difference of oxidative damage to the RNA. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with our"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "that"

Phrase: "the difference of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "bound to RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "may"

Phrase: "result in the difference of oxidative damage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0010957:Damage [Injury or Poisoning]
   748   C0311404:Oxidative [Functional Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]
   748   C1883709:Damage [Functional Concept]
   748   C2825142:Result [Finding]

Phrase: "to the RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.318: In conclusion, we showed that redox-active iron bound to ribosomes oxidizes rRNA in AD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "bound to ribosomes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0035553:Ribosomes [Cell Component]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   756 E C2984240:Ribosome [Functional Concept]

Phrase: "oxidizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "rRNA in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.319: Other redox-active metals could also be involved, and will be the topic for future studies. 

Phrase: "Other redox-active metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0025552:Metals [Inorganic Chemical]
   743 E C2986473:Metallic [Qualitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "will"

Phrase: "be"

Phrase: "the topic for future studies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1522168:TOPIC [Functional Concept]
   760   C1555712:topic [Idea or Concept]
Processing 00000000.tx.320: A case for copper has been made in AD pathophysiology based on increased levels (37) and that copper has specific high affinity interaction with A (49, 50), binding to A/APP, playing a role in regulating oxidative stress (51, 52).  

Phrase: "A case for copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "made in AD pathophysiology"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0031847:pathophysiology [Functional Concept]
   760   C0277785:Pathophysiology [Qualitative Concept]
   726   C1881534:Make [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "based on increased levels"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "that copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "has"

Phrase: "specific high affinity interaction with A (49,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "binding to A/APP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C3538722:APP [Laboratory Procedure]

Phrase: "playing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:playing [Daily or Recreational Activity]
  1000   C0600138:playing [Finding]

Phrase: "a role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.321: FOOTNOTES  * This work was supported by National Institutes of Health Grants NS38648 (to M. A. S.), AG14249 (to G. P.), and GM26796 (to W. C. M.) and grants from the Alzheimer's Association (to M. A. S. and G. P.), Philip Morris USA Inc., and Philip Morris International (to K. H. and G. P.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grants NS38648"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "A."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "AG14249"

Phrase: "("

Phrase: "to G. P."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "GM26796"

Phrase: "("

Phrase: "to W. C."

Phrase: "M.)"

Phrase: "and"

Phrase: "grants from the Alzheimer's Association"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0018173:Grants [Quantitative Concept]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "A. S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "G. P."

Phrase: ")"

Phrase: ","

Phrase: "Philip Morris USA Inc.,"

Phrase: "and"

Phrase: "Philip Morris"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "("

Phrase: "to K. H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "G. P."

Phrase: ")."
Processing 00000000.tx.322: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.323: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.324: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.325: The on-line version of this article (available at http://www.jbc.org) contains Fig. 

Phrase: "The on-line version of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "(available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jbc.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.326: S1. 

Phrase: "S1."
Processing 00000000.tx.327: To whom correspondence should be addressed: Institute of Pathology, Case Western Reserve University, 2085 Adelbert Rd., Cleveland, OH 44106. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Institute of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "2085 Adelbert Rd.,"

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]
Processing 00000000.tx.328: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.329: 216-368-2488; 

Phrase: "216-368-2488"

Phrase: ";"
Processing 00000000.tx.330: Fax: 216-368-8964; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "216-368-8964"

Phrase: ";"
Processing 00000000.tx.331: E-mail: george.perry{at}case.edu . 1 The abbreviations used are: AD, Alzheimer disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "george.perry{at}case.edu . 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   799   C0868928:Case [Functional Concept]
   799   C1706255:CASE [Medical Device]
   799   C1706256:Case [Conceptual Entity]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.332: APP, amyloid protein precursor; 

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid protein precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.333: DAB, 3,3'-diaminobenzidine; 

Phrase: "DAB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086162:Dab [Food]
  1000   C1081457:dab [Fish]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3'-diaminobenzidine"

Phrase: ";"
Processing 00000000.tx.334: eEF, eukaryotic elongation factor; 

Phrase: "eEF,"

Phrase: "eukaryotic elongation factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086206:Elongation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.335: 8-OHG, 8-hydroxyguanosine; 

Phrase: "8-OHG,"

Phrase: "8-hydroxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050092:8-hydroxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.336: MES, 2-(N-morpholino)ethanesulfonic acid; 

Phrase: "MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(N-morpholino"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881903:Morpholino [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "ethanesulfonic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206794:ethanesulfonic acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.337: NFT, neurofibrillary tangles; 

Phrase: "NFT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.338: OD, optical density; 

Phrase: "OD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029421:OD [Disease or Syndrome]
  1000   C0439164:OD [Quantitative Concept]
  1000   C1512019:OD [Intellectual Product]

Phrase: "optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.339: PMI, postmortem interval; 

Phrase: "PMI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417244:PMI [Gene or Genome]
  1000   C1418674:PMI [Gene or Genome]
  1000   C1823304:PMI [Gene or Genome]

Phrase: "postmortem interval"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.340: RT, reverse transcription; 

Phrase: "RT,"

Phrase: "reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.341: nt, nucleotide(s). 

Phrase: "nt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.342: 2 T. 

Phrase: "2 T."
Processing 00000000.tx.343: Hofer and G. 

Phrase: "Hofer"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.344: Perry, unpublished observation.  

Phrase: "Perry,"

Phrase: "unpublished observation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.345: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cutler, R. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cutler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: G., Kelly, J., Storie, K., Pedersen, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kelly,"

Phrase: "J.,"

Phrase: "Storie,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pedersen,"

Phrase: "W."
Processing 00000000.tx.347: A., Tammara, A., Hatanpaa, K., Troncoso, J. 

Phrase: "A.,"

Phrase: "Tammara,"

Phrase: "A.,"

Phrase: "Hatanpaa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Troncoso,"

Phrase: "J."
Processing 00000000.tx.348: C., and Mattson, M. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.350: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.351: Natl. 

Phrase: "Natl."
Processing 00000000.tx.352: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.353: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.354: U. 

Phrase: "U."
Processing 00000000.tx.355: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.356: A. 

Phrase: "A."
Processing 00000000.tx.357: 101, 20702075[Abstract/Free FullText] Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. 

Phrase: "101,"

Phrase: "20702075"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nunomura,"

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aliev,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Balraj,"

Phrase: "E."
Processing 00000000.tx.358: K., Jones, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.359: K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ghanbari,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wataya,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Chiba,"

Phrase: "S."

Phrase: ","

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.360: S., Petersen, R. 

Phrase: "S."

Phrase: ","

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.361: B., and Smith, M. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: A. 

Phrase: "A."
Processing 00000000.tx.363: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.364: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.365: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.366: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.367: 60, 759767[Medline] [OrderarticleviaInfotrieve] Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. 

Phrase: "60,"

Phrase: "759767"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pratico,"

Phrase: "D."

Phrase: ","

Phrase: "Uryu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Trojanoswki,"

Phrase: "J."
Processing 00000000.tx.368: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.369: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.371: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.372: 21, 41834187[Abstract/Free FullText] Smith, M. 

Phrase: "21,"

Phrase: "41834187"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: A., Kutty, R. 

Phrase: "A.,"

Phrase: "Kutty,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: K., Richey, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Richey,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.375: L., Yan, S. 

Phrase: "L., Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: D., Stern, D., Chader, G. 

Phrase: "D."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "Chader,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.377: J., Wiggert, B., Petersen, R. 

Phrase: "J.,"

Phrase: "Wiggert,"

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.378: B., and Perry, G. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.379: (1994) Am. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.380: J. 

Phrase: "J."
Processing 00000000.tx.381: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.382: 145, 4247[Abstract] Nunomura, A., Perry, G., Pappolla, M. 

Phrase: "145,"

Phrase: "4247"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nunomura,"

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pappolla,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.383: A., Wade, R., Hirai, K., Chiba, S., and Smith, M. 

Phrase: "A.,"

Phrase: "Wade"

Phrase: ","

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hirai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: A. 

Phrase: "A."
Processing 00000000.tx.385: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.386: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.387: 19, 19591964[Abstract/Free FullText] Nunomura, A., Chiba, S., Lippa, C. 

Phrase: "19,"

Phrase: "19591964"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nunomura,"

Phrase: "A.,"

Phrase: "Chiba,"

Phrase: "S."

Phrase: ","

Phrase: "Lippa,"

Phrase: "C."
Processing 00000000.tx.388: F., Cras, P., Kalaria, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kalaria,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.389: N., Takeda, A., Honda, K., Smith, M. 

Phrase: "N.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Honda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.390: A., and Perry, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: (2004) Neurobiol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.392: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.393: 17, 108113[CrossRef][Medline] [OrderarticleviaInfotrieve] Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. 

Phrase: "17,"

Phrase: "108113"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Castegna,"

Phrase: "A.,"

Phrase: "Aksenov,"

Phrase: "M."

Phrase: ","

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Thongboonkerd,"

Phrase: "V.,"

Phrase: "Klein,"

Phrase: "J."
Processing 00000000.tx.394: B., Pierce, W. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Pierce,"

Phrase: "W."
Processing 00000000.tx.395: M., Booze, R., Markesbery, W. 

Phrase: "M."

Phrase: ","

Phrase: "Booze,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.396: R., and Butterfield, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.397: A. 

Phrase: "A."
Processing 00000000.tx.398: (2002) Free Radic. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.399: Biol. 

Phrase: "Biol."
Processing 00000000.tx.400: Med. 

Phrase: "Med."
Processing 00000000.tx.401: 33, 562571[CrossRef][Medline] [OrderarticleviaInfotrieve] Lovell, M. 

Phrase: "33,"

Phrase: "562571"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: A., and Markesbery, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.403: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: (2001) Arch. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.405: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.406: 58, 392396[Abstract/Free FullText] Gabbita, S. 

Phrase: "58,"

Phrase: "392396"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gabbita,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.407: P., Lovell, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: A., and Markesbery, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.409: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.410: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.411: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.412: 71, 20342040[Medline] [OrderarticleviaInfotrieve] van Rensburg, S. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "20342040"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] van Rensburg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.413: J., Berman, P., Potocnik, F., MacGregor, P., Hon, D., and de Villiers, N. 

Phrase: "J.,"

Phrase: "Berman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Potocnik,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "MacGregor,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hon,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "de Villiers,"

Phrase: "N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.414: (2004) Metab. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Metab."
Processing 00000000.tx.415: Brain Dis. 

Phrase: "Brain Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.416: 19, 8996[CrossRef][Medline] [OrderarticleviaInfotrieve] Morris, C. 

Phrase: "19,"

Phrase: "8996"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morris,"

Phrase: "C."
Processing 00000000.tx.417: M., Kerwin, J. 

Phrase: "M."

Phrase: ","

Phrase: "Kerwin,"

Phrase: "J."
Processing 00000000.tx.418: M., and Edwardson, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Edwardson,"

Phrase: "J."
Processing 00000000.tx.419: A. 

Phrase: "A."
Processing 00000000.tx.420: (1994) Neurodegeneration 3, 267275[Medline] [OrderarticleviaInfotrieve] Connor, J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neurodegeneration 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "267275"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Connor,"

Phrase: "J."
Processing 00000000.tx.421: R., Menzies, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Menzies,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.422: L., St. 

Phrase: "L., St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.423: Martin, S. 

Phrase: "Martin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.424: M., and Mufson, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mufson,"

Phrase: "E."
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.427: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.428: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.429: 31, 7583[CrossRef][Medline] [OrderarticleviaInfotrieve] Smith, M. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "7583"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: A., Harris, P. 

Phrase: "A.,"

Phrase: "Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.431: L., Sayre, L. 

Phrase: "L., Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.432: M., and Perry, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.433: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.434: Natl. 

Phrase: "Natl."
Processing 00000000.tx.435: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.436: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.437: U. 

Phrase: "U."
Processing 00000000.tx.438: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: A. 

Phrase: "A."
Processing 00000000.tx.440: 94, 98669868[Abstract/Free FullText] Connor, J. 

Phrase: "94,"

Phrase: "98669868"

Phrase: "[Abstract/Free FullText"

Phrase: "] Connor,"

Phrase: "J."
Processing 00000000.tx.441: R., Snyder, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Snyder,"

Phrase: "B."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.442: S., Beard, J. 

Phrase: "S."

Phrase: ","

Phrase: "Beard,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0221982:Beard [Body Part, Organ, or Organ Component]
  1000   C1266881:Beard [Body Part, Organ, or Organ Component]
  1000   C1280542:Beard [Body Part, Organ, or Organ Component]

Phrase: "J."
Processing 00000000.tx.443: L., Fine, R. 

Phrase: "L., Fine, R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: E., and Mufson, E. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Mufson,"

Phrase: "E."
Processing 00000000.tx.445: J. 

Phrase: "J."
Processing 00000000.tx.446: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.447: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.448: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.449: 31, 327335[Medline] [OrderarticleviaInfotrieve] Quintana, C., Lancin, M., Marhic, C., Perez, M., Martin-Benito, J., Avila, J., and Carrascosa, J. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "327335"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Quintana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1896479:Quintana [Fish]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lancin,"

Phrase: "M."

Phrase: ","

Phrase: "Marhic,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Perez,"

Phrase: "M."

Phrase: ","

Phrase: "Martin-Benito,"

Phrase: "J.,"

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Carrascosa,"

Phrase: "J."
Processing 00000000.tx.450: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.451: (2000) Cell. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.452: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.453: Biol. 

Phrase: "Biol."
Processing 00000000.tx.454: 46, 807820[Medline] [OrderarticleviaInfotrieve] Rogers, J. 

Phrase: "46,"

Phrase: "807820"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J."
Processing 00000000.tx.455: T., Randall, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Randall,"

Phrase: "J."
Processing 00000000.tx.456: D., Cahill, C. 

Phrase: "D."

Phrase: ","

Phrase: "Cahill,"

Phrase: "C."
Processing 00000000.tx.457: M., Eder, P. 

Phrase: "M."

Phrase: ","

Phrase: "Eder,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. 

Phrase: "S."

Phrase: ","

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Gunshin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leiter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "McPhee,"

Phrase: "J.,"

Phrase: "Sarang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.459: S., Utsuki, T., Greig, N. 

Phrase: "S."

Phrase: ","

Phrase: "Utsuki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Greig,"

Phrase: "N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.460: H., Lahiri, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lahiri,"

Phrase: "D."
Processing 00000000.tx.461: K., Tanzi, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: E., Bush, A. 

Phrase: "E.,"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.463: I., Giordano, T., and Gullans, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Giordano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Gullans,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Biol. 

Phrase: "Biol."
Processing 00000000.tx.467: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.468: 277, 4551845528[Abstract/Free FullText] Henle, E. 

Phrase: "277,"

Phrase: "4551845528"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henle,"

Phrase: "E."
Processing 00000000.tx.469: S., Luo, Y., Gassmann, W., and Linn, S. 

Phrase: "S."

Phrase: ","

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Gassmann,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Linn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.471: Biol. 

Phrase: "Biol."
Processing 00000000.tx.472: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.473: 271, 2117721186[Abstract/Free FullText] Luo, Y., Henle, E. 

Phrase: "271,"

Phrase: "2117721186"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Henle,"

Phrase: "E."
Processing 00000000.tx.474: S., and Linn, S. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Linn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.476: Biol. 

Phrase: "Biol."
Processing 00000000.tx.477: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.478: 271, 2116721176[Abstract/Free FullText] Henle, E. 

Phrase: "271,"

Phrase: "2116721176"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henle,"

Phrase: "E."
Processing 00000000.tx.479: S., Han, Z., Tang, N., Rai, P., Luo, Y., and Linn, S. 

Phrase: "S."

Phrase: ","

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "Z.,"

Phrase: "Tang,"

Phrase: "N.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "Rai,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539761:RAI [Amino Acid, Peptide, or Protein]
  1000   C3539762:RAI [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Linn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.480: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 274, 962971[Abstract/Free FullText] Luo, Y., Han, Z., Chin, S. 

Phrase: "274,"

Phrase: "962971"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "Z.,"

Phrase: "Chin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008114:Chin [Body Location or Region]
  1000   C1284862:Chin [Body Location or Region]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.484: M., and Linn, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Linn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.485: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.486: Natl. 

Phrase: "Natl."
Processing 00000000.tx.487: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.488: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.489: U. 

Phrase: "U."
Processing 00000000.tx.490: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: A. 

Phrase: "A."
Processing 00000000.tx.492: 91, 1243812442[Abstract/Free FullText] Lloyd, D. 

Phrase: "91,"

Phrase: "1243812442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lloyd,"

Phrase: "D."
Processing 00000000.tx.493: R., and Phillips, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Phillips,"

Phrase: "D."
Processing 00000000.tx.494: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.495: (1999) Mutat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mutat."
Processing 00000000.tx.496: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.497: 424, 2336[CrossRef][Medline] [OrderarticleviaInfotrieve] Ding, Q., Dimayuga, E., Markesbery, W. 

Phrase: "424,"

Phrase: "2336"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "Q.,"

Phrase: "Dimayuga,"

Phrase: "E.,"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.498: R., and Keller, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Keller,"

Phrase: "J."
Processing 00000000.tx.499: N. 

Phrase: "N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.500: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.501: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.502: 91, 12111218[CrossRef][Medline] [OrderarticleviaInfotrieve] Shiman, R., and Draper, D. 

Phrase: "91,"

Phrase: "12111218"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shiman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Draper,"

Phrase: "D."
Processing 00000000.tx.503: E. 

Phrase: "E."
Processing 00000000.tx.504: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.505: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.506: Biol. 

Phrase: "Biol."
Processing 00000000.tx.507: 302, 7991[CrossRef][Medline] [OrderarticleviaInfotrieve] Berens, C., Streicher, B., Schroeder, R., and Hillen, W. 

Phrase: "302,"

Phrase: "7991"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Berens,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Streicher,"

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Schroeder,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hillen,"

Phrase: "W."
Processing 00000000.tx.508: (1998) Chem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.509: Biol. 

Phrase: "Biol."
Processing 00000000.tx.510: 5, 163175[CrossRef][Medline] [OrderarticleviaInfotrieve] Huang, X., Atwood, C. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "163175"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang,"

Phrase: "X.,"

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.511: S., Hartshorn, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: A., Multhaup, G., Goldstein, L. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.513: E., Scarpa, R. 

Phrase: "E.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: C., Cuajungco, M. 

Phrase: "C., Cuajungco,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.515: P., Gray, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.516: N., Lim, J., Moir, R. 

Phrase: "N.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.517: D., Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.518: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.519: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.520: (1999) Biochemistry 38, 76097616[CrossRef][Medline] [OrderarticleviaInfotrieve] Rottkamp, C. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "76097616"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rottkamp,"

Phrase: "C."
Processing 00000000.tx.521: A., Raina, A. 

Phrase: "A.,"

Phrase: "Raina,"

Phrase: "A."
Processing 00000000.tx.522: K., Zhu, X., Gaier, E., Bush, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhu,"

Phrase: "X.,"

Phrase: "Gaier,"

Phrase: "E.,"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.523: I., Atwood, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.524: S., Chevion, M., Perry, G., and Smith, M. 

Phrase: "S."

Phrase: ","

Phrase: "Chevion,"

Phrase: "M."

Phrase: ","

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: A. 

Phrase: "A."
Processing 00000000.tx.526: (2001) Free Radic. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Med. 

Phrase: "Med."
Processing 00000000.tx.529: 30, 447450[CrossRef][Medline] [OrderarticleviaInfotrieve] Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. 

Phrase: "30,"

Phrase: "447450"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hirai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Aliev,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nunomura,"

Phrase: "A.,"

Phrase: "Fujioka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.530: L., Atwood, C. 

Phrase: "L., Atwood,"

Phrase: "C."
Processing 00000000.tx.531: S., Johnson, A. 

Phrase: "S."

Phrase: ","

Phrase: "Johnson,"

Phrase: "A."
Processing 00000000.tx.532: B., Kress, Y., Vinters, H. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Kress,"

Phrase: "Y.,"

Phrase: "Vinters,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.533: V., Tabaton, M., Shimohama, S., Cash, A. 

Phrase: "V., Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Cash,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680861:cash [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.534: D., Siedlak, S. 

Phrase: "D."

Phrase: ","

Phrase: "Siedlak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.535: L., Harris, P. 

Phrase: "L., Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.536: L., Jones, P. 

Phrase: "L., Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.537: K., Petersen, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.538: B., Perry, G., and Smith, M. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.539: A. 

Phrase: "A."
Processing 00000000.tx.540: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.541: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.542: 21, 30173023[Abstract/Free FullText] Smith, M. 

Phrase: "21,"

Phrase: "30173023"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: A., Nunomura, A., Zhu, X., Takeda, A., and Perry, G. 

Phrase: "A.,"

Phrase: "Nunomura,"

Phrase: "A.,"

Phrase: "Zhu,"

Phrase: "X.,"

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: (2000) Antioxid. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Antioxid."
Processing 00000000.tx.545: Redox Signal. 

Phrase: "Redox Signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.546: 2, 413420[CrossRef][Medline] [OrderarticleviaInfotrieve] Khachaturian, Z. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "413420"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Khachaturian,"

Phrase: "Z."
Processing 00000000.tx.547: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: (1985) Arch. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.549: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.550: 42, 10971105[CrossRef][Medline] [OrderarticleviaInfotrieve] Sayre, L. 

Phrase: "42,"

Phrase: "10971105"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.551: M., Perry, G., Harris, P. 

Phrase: "M."

Phrase: ","

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.552: L., Liu, Y., Schubert, K. 

Phrase: "L., Liu,"

Phrase: "Y.,"

Phrase: "Schubert,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.553: A., and Smith, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.554: A. 

Phrase: "A."
Processing 00000000.tx.555: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.557: 74, 270279[CrossRef][Medline] [OrderarticleviaInfotrieve] Shan, X., Tashiro, H., and Lin, C. 

Phrase: "74,"

Phrase: "270279"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shan,"

Phrase: "X.,"

Phrase: "Tashiro,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C."
Processing 00000000.tx.558: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.559: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.560: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.561: 23, 49134921[Abstract/Free FullText] Chen, B. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "49134921"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "B."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.562: X., Szabolcs, M. 

Phrase: "X.,"

Phrase: "Szabolcs,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: J., Matsushima, A. 

Phrase: "J.,"

Phrase: "Matsushima,"

Phrase: "A."
Processing 00000000.tx.564: Y., and Erlanger, B. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Erlanger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442998:Erlanger [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.565: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.566: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.567: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.568: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.569: 44, 819824[Abstract/Free FullText] Merrick, W. 

Phrase: "44,"

Phrase: "819824"

Phrase: "[Abstract/Free FullText"

Phrase: "] Merrick,"

Phrase: "W."
Processing 00000000.tx.570: C. 

Phrase: "C."
Processing 00000000.tx.571: (1979) Methods Enzymol. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.572: 60, 108123[Medline] [OrderarticleviaInfotrieve] Kemper, W. 

Phrase: "60,"

Phrase: "108123"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kemper,"

Phrase: "W."
Processing 00000000.tx.573: M., and Merrick, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Merrick,"

Phrase: "W."
Processing 00000000.tx.574: C. 

Phrase: "C."
Processing 00000000.tx.575: (1979) Methods Enzymol. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.576: 60, 638648[Medline] [OrderarticleviaInfotrieve] Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. 

Phrase: "60,"

Phrase: "638648"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Alberts,"

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Bray,"

Phrase: "D."

Phrase: ","

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Raff,"

Phrase: "M."

Phrase: ","

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.577: D. 

Phrase: "D."
Processing 00000000.tx.578: (1994) Molecular Biology of the Cell, 3rd Ed., Garland Publishing, Inc., New York Colwell, B. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Molecular Biology of the Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   797   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "3rd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Garland Publishing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034037:Publishing [Occupational Activity]

Phrase: "Inc.,"

Phrase: "New York Colwell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "B."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.579: A., and Morris, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Morris,"

Phrase: "D."
Processing 00000000.tx.580: L., Jr. 

Phrase: "L., Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.581: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.582: Inorg. 

Phrase: "Inorg."
Processing 00000000.tx.583: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.584: 94, 100105[CrossRef][Medline] [OrderarticleviaInfotrieve] Lovell, M. 

Phrase: "94,"

Phrase: "100105"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: A., Robertson, J. 

Phrase: "A.,"

Phrase: "Robertson,"

Phrase: "J."
Processing 00000000.tx.586: D., Teesdale, W. 

Phrase: "D."

Phrase: ","

Phrase: "Teesdale,"

Phrase: "W."
Processing 00000000.tx.587: J., Campbell, J. 

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.588: L., and Markesbery, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.589: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.590: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.591: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.592: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.593: 158, 4752[CrossRef][Medline] [OrderarticleviaInfotrieve] Schipper, H. 

Phrase: "158,"

Phrase: "4752"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schipper,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.594: M., Cisse, S., and Stopa, E. 

Phrase: "M."

Phrase: ","

Phrase: "Cisse,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stopa,"

Phrase: "E."
Processing 00000000.tx.595: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.596: (1995) Ann. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.597: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.598: 37, 758768[CrossRef][Medline] [OrderarticleviaInfotrieve] Deibel, M. 

Phrase: "37,"

Phrase: "758768"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Deibel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.599: A., Ehmann, W. 

Phrase: "A.,"

Phrase: "Ehmann,"

Phrase: "W."
Processing 00000000.tx.600: D., and Markesbery, W. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.601: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.602: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.603: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.604: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.605: 143, 137142[CrossRef][Medline] [OrderarticleviaInfotrieve] Polacek, N., and Barta, A. 

Phrase: "143,"

Phrase: "137142"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Polacek,"

Phrase: "N.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "Barta,"

Phrase: "A."
Processing 00000000.tx.606: (1998) RNA (N. Y.) 

Phrase: "(1998"

Phrase: ")"

Phrase: "RNA (N. Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1419492:RNA Y [Gene or Genome]
   901   C3496276:nucleus Y [Body Part, Organ, or Organ Component]

Phrase: ")"
Processing 00000000.tx.607: 4, 12821294 Gonzalez, R. 

Phrase: "4,"

Phrase: "12821294 Gonzalez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.608: L., Jr., and Tinoco, I., Jr. 

Phrase: "L., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Tinoco,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.609: (2001) Methods Enzymol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.610: 338, 421443[Medline] [OrderarticleviaInfotrieve] Pyle, A. 

Phrase: "338,"

Phrase: "421443"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pyle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0265294:pyle [Disease or Syndrome]

Phrase: "A."
Processing 00000000.tx.611: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.612: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.613: Biol. 

Phrase: "Biol."
Processing 00000000.tx.614: Inorg. 

Phrase: "Inorg."
Processing 00000000.tx.615: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.616: 7, 679690[CrossRef][Medline] [OrderarticleviaInfotrieve] Cate, J. 

Phrase: "7,"

Phrase: "679690"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413812:CATE [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.617: H., and Doudna, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Doudna,"

Phrase: "J."
Processing 00000000.tx.618: A. 

Phrase: "A."
Processing 00000000.tx.619: (1996) Structure 4, 12211229[CrossRef][Medline] [OrderarticleviaInfotrieve] Mann, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Structure 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "12211229"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mann,"

Phrase: "D."
Processing 00000000.tx.620: M., Neary, D., Yates, P. 

Phrase: "M."

Phrase: ","

Phrase: "Neary,"

Phrase: "D."

Phrase: ","

Phrase: "Yates,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.621: O., Lincoln, J., Snowden, J. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Lincoln,"

Phrase: "J.,"

Phrase: "Snowden,"

Phrase: "J."
Processing 00000000.tx.622: S., and Stanworth, P. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stanworth,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.623: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.624: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.625: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.626: Psychiatry 44, 97102[Abstract] Sajdel-Sulkowska, E. 

Phrase: "Psychiatry 44,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "97102"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sajdel-Sulkowska,"

Phrase: "E."
Processing 00000000.tx.627: M., and Marotta, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Marotta,"

Phrase: "C."
Processing 00000000.tx.628: A. 

Phrase: "A."
Processing 00000000.tx.629: (1984) Science 225, 947949[Medline] [OrderarticleviaInfotrieve] Langstrom, N. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Science 225,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "947949"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Langstrom,"

Phrase: "N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.630: S., Anderson, J. 

Phrase: "S."

Phrase: ","

Phrase: "Anderson,"

Phrase: "J."
Processing 00000000.tx.631: P., Lindroos, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lindroos,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.632: G., Winblad, B., and Wallace, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "W."
Processing 00000000.tx.633: C. 

Phrase: "C."
Processing 00000000.tx.634: (1989) Brain Res. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.635: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.636: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.637: 5, 259269[Medline] [OrderarticleviaInfotrieve] Johnson, G., Gotlib, J., Haroutunian, V., Bierer, L., Nairn, A. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "259269"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Johnson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gotlib,"

Phrase: "J.,"

Phrase: "Haroutunian,"

Phrase: "V.,"

Phrase: "Bierer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nairn,"

Phrase: "A."
Processing 00000000.tx.638: C., Merril, C., and Wallace, W. 

Phrase: "C., Merril,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "W."
Processing 00000000.tx.639: (1992) Brain Res. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.640: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.641: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.642: 15, 319326[Medline] [OrderarticleviaInfotrieve] Ban, N., Nissen, P., Hansen, J., Moore, P. 

Phrase: "15,"

Phrase: "319326"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ban,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683610:ban [Social Behavior]

Phrase: "N.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "Nissen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hansen,"

Phrase: "J.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.643: B., and Steitz, T. 

Phrase: "B.,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Steitz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.644: A. 

Phrase: "A."
Processing 00000000.tx.645: (2000) Science 289, 905920[Abstract/Free FullText] Atwood, C. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 289,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "905920"

Phrase: "[Abstract/Free FullText"

Phrase: "] Atwood,"

Phrase: "C."
Processing 00000000.tx.646: S., Scarpa, R. 

Phrase: "S."

Phrase: ","

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.647: C., Huang, X., Moir, R. 

Phrase: "C., Huang,"

Phrase: "X.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.648: D., Jones, W. 

Phrase: "D."

Phrase: ","

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.649: D., Fairlie, D. 

Phrase: "D."

Phrase: ","

Phrase: "Fairlie,"

Phrase: "D."
Processing 00000000.tx.650: P., Tanzi, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.651: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.652: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.653: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.654: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.655: 75, 12191233[CrossRef][Medline] [OrderarticleviaInfotrieve] Dong, J., Atwood, C. 

Phrase: "75,"

Phrase: "12191233"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dong,"

Phrase: "J.,"

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.656: S., Anderson, V. 

Phrase: "S."

Phrase: ","

Phrase: "Anderson,"

Phrase: "V."
Processing 00000000.tx.657: E., Siedlak, S. 

Phrase: "E.,"

Phrase: "Siedlak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.658: L., Smith, M. 

Phrase: "L., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: A., Perry, G., and Carey, P. 

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Carey,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.660: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.661: (2003) Biochemistry 42, 27682773[CrossRef][Medline] [OrderarticleviaInfotrieve] Huang, X., Cuajungco, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "27682773"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang,"

Phrase: "X.,"

Phrase: "Cuajungco,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.662: P., Atwood, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.663: S., Hartshorn, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.664: A., Tyndall, J. 

Phrase: "A.,"

Phrase: "Tyndall,"

Phrase: "J."
Processing 00000000.tx.665: D., Hanson, G. 

Phrase: "D."

Phrase: ","

Phrase: "Hanson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.666: R., Stokes, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stokes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551086:Stokes [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.667: C., Leopold, M., Multhaup, G., Goldstein, L. 

Phrase: "C., Leopold,"

Phrase: "M."

Phrase: ","

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.668: E., Scarpa, R. 

Phrase: "E.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.669: C., Saunders, A. 

Phrase: "C., Saunders,"

Phrase: "A."
Processing 00000000.tx.670: J., Lim, J., Moir, R. 

Phrase: "J.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.671: D., Glabe, C., Bowden, E. 

Phrase: "D."

Phrase: ","

Phrase: "Glabe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bowden,"

Phrase: "E."
Processing 00000000.tx.672: F., Masters, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.673: L., Fairlie, D. 

Phrase: "L., Fairlie,"

Phrase: "D."
Processing 00000000.tx.674: P., Tanzi, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.675: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.676: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.677: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.678: Biol. 

Phrase: "Biol."
Processing 00000000.tx.679: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.680: 274, 3711137116[Abstract/Free FullText] Bayer, T. 

Phrase: "274,"

Phrase: "3711137116"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bayer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.681: A., Schafer, S., Simons, A., Kemmling, A., Kamer, T., Tepest, R., Eckert, A., Schussel, K., Eikenberg, O., Sturchler-Pierrat, C., Abramowski, D., Staufenbiel, M., and Multhaup, G. 

Phrase: "A.,"

Phrase: "Schafer,"

Phrase: "S."

Phrase: ","

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "A.,"

Phrase: "Kemmling,"

Phrase: "A.,"

Phrase: "Kamer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tepest,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Eckert,"

Phrase: "A.,"

Phrase: "Schussel,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eikenberg,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Multhaup,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.682: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.683: Natl. 

Phrase: "Natl."
Processing 00000000.tx.684: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.685: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.686: U. 

Phrase: "U."
Processing 00000000.tx.687: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.688: A. 

Phrase: "A."
Processing 00000000.tx.689: 100, 1418714192[Abstract/Free FullText]

Phrase: "100,"

Phrase: "1418714192"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

